<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy   - RSC Advances (RSC Publishing) DOI:10.1039/C2RA21404K</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2012/ra/c2ra21404k"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":60,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */
(()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i<n.length-1;i++)if("object"!=typeof(r=r[n[i]]))return;r=r[n[n.length-1]]}return r}const p={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},m={};function v(e){if(!e)throw new Error("All loader-config objects require an agent identifier!");if(!m[e])throw new Error("LoaderConfig for ".concat(e," was never set"));return m[e]}function b(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");m[e]=(0,i.D)(t,p),(0,n.Qy)(e,m[e],"loader_config")}const y=(0,n.mF)().o;var w=r(385),x=r(6818);const A={buildEnv:x.Re,bytesSent:{},queryBytesSent:{},customTransaction:void 0,disabled:!1,distMethod:x.gF,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,offset:Math.floor(w._A?.performance?.timeOrigin||w._A?.performance?.timing?.navigationStart||Date.now()),onerror:void 0,origin:""+w._A.location,ptid:void 0,releaseIds:{},session:void 0,xhrWrappable:"function"==typeof w._A.XMLHttpRequest?.prototype?.addEventListener,version:x.q4},E={};function T(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!E[e])throw new Error("Runtime for ".concat(e," was never set"));return E[e]}function _(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");E[e]=(0,i.D)(t,A),(0,n.Qy)(e,E[e],"runtime")}function D(e){return function(e){try{const t=s(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}(e)}},9567:(e,t,r)=>{r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u<s.length;++u)f(s[u],c);(0,i.D)(c,(function(e,t){(0,i.D)(t,(function(t,r){r[0].on(e,r[1])}))}))}delete a[t],r.backlog[t]=null,r.emit("drain-"+t,[])}}r.every((e=>{let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;f<d;f++)s[f].apply(a,r);var l=T()[c[e]];return l&&l.push([p,e,r,a]),a}}function b(e,t){n[e]=w(e).concat(t)}function y(e,t){var r=n[e];if(r)for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)}function w(e){return n[e]||[]}function x(t){return f[t]=f[t]||e(p,t)}function A(e,t){var r=T();p.aborted||(0,o.D)(e,(function(e,n){t=t||"feature",c[n]=t,t in r||(r[t]=[])}))}function E(e){return!!T()[c[e]]}function T(){return p.backlog}}(void 0,"globalEE"),c.ee=u)},5546:(e,t,r)=>{r.d(t,{E:()=>n,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s<e;s++)a.push(o(r,++i).toString(16));return a.join("")}function c(){return s(16)}function u(){return s(32)}},7056:(e,t,r)=>{r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c<t.length;c++)d(a=e[s=t[c]])||(e[s]=r(a,u?s+n:n,i,s,o))},r.flag=i,r;function r(t,r,n,a,s){return d(t)?t:(r||(r=""),nrWrapper[i]=t,u(t,nrWrapper,e),nrWrapper);function nrWrapper(){var i,u,d,f;try{u=this,i=[...arguments],d="function"==typeof n?n(i,u):n||{}}catch(t){c([t,"",[i,u,a],d],e)}o(r+"start",[i,u,a],d,s);try{return f=t.apply(u,i)}catch(e){throw o(r+"err",[i,u,e],d,s),e}finally{o(r+"end",[i,u,f],d,s)}}}function o(r,n,i,o){if(!a||t){var s=a;a=!0;try{e.emit(r,n,i,t,o)}catch(t){c([t,r,n,i],e)}a=s}}}function c(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function u(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){c([e],r)}for(var n in e)o.call(e,n)&&(t[n]=e[n]);return t}function d(e){return!(e&&e instanceof Function&&e.apply&&!e[i])}var f=r(2210),l=r(385);const h={},g=XMLHttpRequest,p="addEventListener",m="removeEventListener";function v(e){var t=function(e){return(e||n.ee).get("events")}(e);if(h[t.debugId]++)return t;h[t.debugId]=1;var r=s(t,!0);function i(e){r.inPlace(e,[p,m],"-",o)}function o(e,t){return e[1]}return"getPrototypeOf"in Object&&(l.il&&b(document,i),b(l._A,i),b(g.prototype,i)),t.on(p+"-start",(function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var i=(0,f.X)(n,"nr@wrapped",(function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n}));this.wrapped=e[1]=i}})),t.on(m+"-start",(function(e){e[1]=this.wrapped||e[1]})),t}function b(e,t){let r=e;for(;"object"==typeof r&&!Object.prototype.hasOwnProperty.call(r,p);)r=Object.getPrototypeOf(r);for(var n=arguments.length,i=new Array(n>2?n-2:0),o=2;o<n;o++)i[o-2]=arguments[o];r&&t(r,...i)}var y="fetch-",w=y+"body-",x=["arrayBuffer","blob","json","text","formData"],A=l._A.Request,E=l._A.Response,T="prototype",_="nr@context";const D={};function N(e){const t=function(e){return(e||n.ee).get("fetch")}(e);if(!(A&&E&&l._A.fetch))return t;if(D[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[_]&&o[_].dt&&(e=o[_].dt);var a=i.apply(this,r);return t.emit(n+"start",[r,e],a),a.then((function(e){return t.emit(n+"end",[null,e],a),e}),(function(e){throw t.emit(n+"end",[e],a),e}))})}return D[t.debugId]=1,x.forEach((e=>{r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c<a;c++)s[c]=arguments[c];s[0]=o(s[0],"cb-",i,null,!1),s[1]=o(s[1],"cb-",i,null,!1);const u=n.apply(this,s);return i.nextPromise=u,t.emit("propagate",[e,!0],u,!1,!1),u},a.prototype.then[i]=n,t.on("executor-start",(function(e){e[0]=o(e[0],"resolve-",this,null,!1),e[1]=o(e[1],"resolve-",this,null,!1)})),t.on("executor-err",(function(e,t,r){e[1](r)})),t.on("cb-end",(function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)})),t.on("propagate",(function(e,r,n){this.getCtx&&!r||(this.getCtx=function(){if(e instanceof Promise)var r=t.context(e);return r&&r.getCtx?r.getCtx():this})}))}(),t}const B={},F="requestAnimationFrame";function U(e){const t=function(e){return(e||n.ee).get("raf")}(e);if(!l.il||B[t.debugId]++)return t;B[t.debugId]=1;var r=s(t);return r.inPlace(window,[F],"raf-"),t.on("raf-start",(function(e){e[0]=r(e[0],"fn-")})),t}const q={},G="setTimeout",V="setInterval",X="clearTimeout",W="-start",Z="-",$=[G,"setImmediate",V,X,"clearImmediate"];function Q(e){const t=function(e){return(e||n.ee).get("timer")}(e);if(q[t.debugId]++)return t;q[t.debugId]=1;var r=s(t);return r.inPlace(l._A,$.slice(0,2),G+Z),r.inPlace(l._A,$.slice(2,3),V+Z),r.inPlace(l._A,$.slice(3),X+Z),t.on(V+W,(function(e,t,n){e[0]=r(e[0],"fn-",null,n)})),t.on(G+W,(function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)})),t}var Y=r(50);const K={},J=["open","send"];function ee(e){var t=e||n.ee;const r=function(e){return(e||n.ee).get("xhr")}(t);if(K[r.debugId]++)return r;K[r.debugId]=1,v(t);var i=s(r),o=k.Yu.XHR,a=k.Yu.MO,c=k.Yu.PR,u=k.Yu.SI,d="readystatechange",f=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],h=[],g=l._A.XMLHttpRequest.listeners,p=l._A.XMLHttpRequest=function(e){var t=new o(e);function n(){try{r.emit("new-xhr",[t],t),t.addEventListener(d,b,(0,P.m$)(!1))}catch(e){(0,Y.Z)("An error occured while intercepting XHR",e);try{r.emit("internal-error",[e])}catch(e){}}}return this.listeners=g?[...g,n]:[n],this.listeners.forEach((e=>e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e<h.length;e++)m(0,h[e]);h.length&&(h=[])}function E(e,t){return t}return r}},7825:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i<r;i++)n[i]=arguments[i];return function(t){for(var r=arguments.length,n=new Array(r>1?r-1:0),i=1;i<r;i++)n[i-1]=arguments[i];let o=[];return Object.values(e.initializedAgents).forEach((e=>{e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of <".concat(typeof t,"> was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of <".concat(typeof e,"> was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of <".concat(typeof e,"> was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var f=u[d];if(f.getAttribute("src")==r||f.getAttribute("data-webpack")==t+o){s=f;break}}s||(c=!0,(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r),e[r]=[n];var l=(t,n)=>{s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=window.webpackChunkNRBA=window.webpackChunkNRBA||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})();var o={};(()=>{i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i<e.length;i++)t[r=e[i]]=A(this.aggregatedData[r]),t[r].length&&(n=!0),delete this.aggregatedData[r];return n?t:null}}function w(e,t){return null==e?function(e){e?e.c++:e={c:1};return e}(t):t?(t.c||(t=x(t.t)),t.c+=1,t.t+=e,t.sos+=e*e,e>t.max&&(t.max=e),e<t.min&&(t.min=e),t):{t:e}}function x(e){return{t:e,min:e,max:e,sos:e*e,c:1}}function A(e){return"object"!=typeof e?[]:(0,b.D)(e,E)}function E(e,t){return t}var T=i(8632),_=i(4402),D=i(4351);var N=i(7956),O=i(3239),j=i(9251);class S extends h{static featureName=j.t;constructor(e,r){let n=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i<n.allowed_origins.length;i++){var o=(0,X.e)(n.allowed_origins[i]);if(e.hostname===o.hostname&&e.protocol===o.protocol&&e.port===o.port){r=!0;break}}return r}isDtEnabled(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.enabled}excludeNewrelicHeader(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.cors_use_tracecontext_headers}}var Z=i(7825),$=["load","error","abort","timeout"],Q=$.length,Y=t.Yu.REQ,K=c._A.XMLHttpRequest;class J extends h{static featureName=Z.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s<Q;s++)t.addEventListener($[s],this.listener,(0,O.m$)(!1))}function f(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function l(e,t){var r=""+G(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function h(e,t){var r=""+G(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,p.z)()}function m(e,t){t instanceof K&&"load"===e[0]&&n.emit("xhr-load-added",[e[1],e[2]],t)}function v(e,t){t instanceof K&&"load"===e[0]&&n.emit("xhr-load-removed",[e[1],e[2]],t)}function b(e,t,r){t instanceof K&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,p.z)()))}function y(e,t){this.xhrCbStart&&n.emit("xhr-cb-time",[(0,p.z)()-this.xhrCbStart,this.onload,t],t)}function w(e){var t,r=e[1]||{};"string"==typeof e[0]?t=e[0]:e[0]&&e[0].url?t=e[0].url:c._A?.URL&&e[0]&&e[0]instanceof URL&&(t=e[0].href),t&&(this.parsedOrigin=(0,X.e)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=o.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if("string"==typeof e[0]||c._A?.URL&&e[0]&&e[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),s(i.headers,n)&&(this.dt=n),e.length>1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o<Q;o++)t.removeEventListener($[o],this.listener,!1);r.aborted||(n.duration=(0,p.z)()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==r.status&&(r.status=0):_(this,t),n.cbTime=this.cbTime,i("xhr",[r,n,this.startTime,this.endTime,"xhr"],this,e.D.ajax))}}function T(e,t){var r=(0,X.e)(t),n=e.params;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}function _(e,t){e.params.status=t.status;var r=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?V(e.response):"text"===r||""===r||void 0===r?V(e.responseText):void 0}(t,e.lastSize);if(r&&(e.metrics.rxSize=r),e.sameOrigin){var n=t.getResponseHeader("X-NewRelic-App-Data");n&&(e.params.cat=n.split(", ").pop())}e.loadCaptureCalled=!0}n.on("new-xhr",a),n.on("open-xhr-start",s),n.on("open-xhr-end",u),n.on("send-xhr-start",d),n.on("xhr-cb-time",f),n.on("xhr-load-added",l),n.on("xhr-load-removed",h),n.on("xhr-resolved",g),n.on("addEventListener-end",m),n.on("removeEventListener-end",v),n.on("fn-end",y),n.on("fetch-before-start",w),n.on("fetch-start",x),n.on("fn-start",b),n.on("fetch-done",A)}(r,this.ee,this.handler,this.dt),this.importAggregator())}}var ee=i(3614);const{BST_RESOURCE:te,RESOURCE:re,START:ne,END:ie,FEATURE_NAME:oe,FN_END:ae,FN_START:se,PUSH_STATE:ce}=ee;var ue=i(7836);const{FEATURE_NAME:de,START:fe,END:le,BODY:he,CB_END:ge,JS_TIME:pe,FETCH:me,FN_START:ve,CB_START:be,FN_END:ye}=ue;var we=i(4649);class xe extends h{static featureName=we.t;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})();</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Samuel G. Awuah"/><meta name="DC.Creator" content="Youngjae You"/><meta name="DC.title" content="Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2012/10/29"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C2RA21404K"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy  "/><meta name="citation_author" content="Samuel G. Awuah"/><meta name="citation_author" content="Youngjae You"/><meta name="citation_online_date" content="2012/09/07"/><meta name="citation_date" content="2012"/><meta name="citation_journal_title" content="RSC Advances"/><meta name="citation_volume" content="2"/><meta name="citation_issue" content="30"/><meta name="citation_firstpage" content="11169"/><meta name="citation_lastpage" content="11183"/><meta name="citation_doi" content="10.1039/C2RA21404K"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2012/ra/c2ra21404k"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2012/ra/c2ra21404k"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2012/ra/c2ra21404k"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/prospect.js?ver=6_2_1"> </script><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2012/ra/c2ra21404k">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c2ra90086f)" href="/en/content/articlehtml/2012/ra/c2ra90086f" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c2ra21811a)" href="/en/content/articlehtml/2012/ra/c2ra21811a" target="_BLANK">Next Article</a></span></div><div class="right_head"> </div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C2RA21404K">10.1039/C2RA21404K</a>
(Review Article)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2046-2069/2011">RSC Adv.</a></span>, 2012, <strong>2</strong>, 11169-11183<div id="chemnav"><a class="tab" onmouseover="this.style.cursor='pointer';" title="Select to toggle highlighting of compound names" onclick="toggleColour('TC');"><span alt="Show Compounds button" id="btnTC">Show Compounds</span></a><input id="inpTC" type="hidden" value="off"/><a class="tab" onmouseover="this.style.cursor='pointer';" title="Select to toggle highlighting of chem-ontology terms" onclick="toggleColour('CH');"><span alt="Show Chemical Terms button" id="btnCH">Show Chemical Terms</span></a><input id="inpCH" type="hidden" value="off"/></div></div><h1 id="sect222"><span class="title_heading">Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
      <span class="bold">
        
          
            Samuel G. 
            Awuah
          
          
        
      </span><sup><span class="sup_ref italic">ab</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Youngjae 
            You
          
          
        
      </span>*<sup><span class="sup_ref italic">ab</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">Department of Pharmaceutical Sciences, University of Oklahoma, Health Sciences Center, Oklahoma City, Oklahoma 73117, United States</span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019, United States. E-mail: <a href="mailto:youngjae-you@ouhsc.edu">youngjae-you@ouhsc.edu</a>;   Tel: +1 405 271 6593x47473</span>
    </p><div id="art-admin"><span class="italic bold">Received 
      9th July 2012
    </span><span class="bold italic">, Accepted 6th September 2012</span></div><p class="bold italic">First published on 7th September 2012</p><hr/><div class="abstract"><h2>Abstract</h2><p>Photodynamic therapy (PDT) has shown promise as an effective treatment modality for cancers and other localized diseases, such as age-related macular degeneration and actinic keratosis. PDT relies on light, photosensitizer and oxygen as elements in its mechanism of action. BODIPY photosensitizers that have been under extensive study over the past decade have been demonstrated as a new class of photosensitizers. In this review, we attempt to summarize the decade-long study of BODIPY-based photosensitizers. We provide an overview of the superior photophysical properties possessed by BODIPY-based agents and the various synthetic strategies employed that have led to improved and selective and/or targeted photosensitizers.</p></div><hr/><table><tr><td class="biogPlate"><img alt="Samuel G. Awuah" src="/image/article/2012/RA/c2ra21404k/c2ra21404k-p1.gif"/><p><span class="graphic_title">Samuel G. Awuah</span></p></td><td><i><p>Samuel G. Awuah received a B. Sc. from Kwame Nkrumah University of Science and Technology, Kumasi Ghana. He is presently completing a PhD at the University of Oklahoma in the area of Organic Chemistry with research focus in Medicinal Chemistry and NIR molecular probes for imaging and photodynamic therapy. His research interests are in the development of light harvesting materials for disease diagnosis and therapy, as well as solar cell applications.</p></i></td></tr></table><table><tr><td class="biogPlate"><img alt="Youngjae You" src="/image/article/2012/RA/c2ra21404k/c2ra21404k-p2.gif"/><p><span class="graphic_title">Youngjae You</span></p></td><td><i><p>Dr Youngjae You is an associate professor at the Department of Pharmaceutical Sciences of the University of Oklahoma Health Sciences Center. He is also a member of the Peggy and Charles Stephenson Cancer Center. He obtained his PhD from Chungnam National University, Korea in 2001 and was a postdoctoral fellow and a research assistant professor at the SUNY Buffalo. He became an assistant professor in South Dakota State University and then moved to OUHSC in 2010. His interests are to develop NIR probes for cancer theranostics, light-controlled drug delivery systems and anticancer agents.</p></i></td></tr></table><hr/>
    
      
      <h2 id="sect275"><span class="a_heading">A. Introduction</span></h2>
      <span>Photodynamic therapy (PDT) is an effective and approved regime for the treatment of certain types of cancers and precancerous inductions, age-related macular degeneration and actinic keratosis.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1–4</span></sup></a> It has also been explored for other diseases, such as localized infections, dermatological and cardiovascular illnesses and wound healing.<a title="Select to navigate to reference" href="#cit5"><sup><span class="sup_ref">5–7</span></sup></a> Three elements are important components for effective photodynamic activity: light, oxygen and a photosensitizer (<span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span>). BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)-based and its aza analogue (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>) PSs (PSs) are a new class of PSs retaining characteristics of fluorescent <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span> such as excellent optical properties and synthetic versatility.<a title="Select to navigate to reference" href="#cit8"><sup><span class="sup_ref">8–10</span></sup></a> This review seeks to summarize and discuss recent achievements in BODIPY-based PSs for the application of oncologic and antimicrobial PDT.</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><img alt="Chromophores of BODIPY and aza-BODIPY." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f1.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title"><span class="CH"><a class="simple" title="ChEBI Ontology link for: Chromophores" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">Chromophores</a></span> of BODIPY and aza-BODIPY.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      
      <h2 id="sect288"><span class="a_heading">B. Three key elements of PDT</span></h2>
      <span>PDT operates by a tripartite modality involving light, a PS and oxygen. A <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> is administered and then the treatment site (<span class="italic">e.g.</span> tumor) is subjected to light irradiation to generate <span class="CH"><a class="simple" title="ChEBI Ontology link for: reactive oxygen species" href="javascript:popupOBO('CHEBI:26523','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26523')">reactive oxygen species</a></span>, especially singlet oxygen from oxygen, to damage target diseases. When a PS is irradiated, it is converted to the triplet state <span class="italic">via</span> intersystem crossing from the singlet state (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>).<a title="Select to navigate to references" href="#cit11"><sup><span class="sup_ref">11</span></sup></a> In what is known as the type II process, the triplet state <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> transfers its energy to molecular oxygen to produce singlet oxygen. In a type I process, a chemical reaction of the excited PS with a substrate occurs, initiating an electron transfer leading to the formation of radicals, which react with molecular oxygen to produce <span class="CH"><a class="simple" title="ChEBI Ontology link for: reactive oxygen species" href="javascript:popupOBO('CHEBI:26523','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26523')">reactive oxygen species</a></span>, such as superoxide, <span class="TC"><a class="simple" title="Chemspider Compound link for:hydrogen peroxide" target="_blank" href="http://www.chemspider.com/Chemical-Structure.763.html">hydrogen peroxide</a></span> and hydroxyl ions.<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a></span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><img alt="PDT action by a simplified Jablonski diagram." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f2.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">PDT action by a simplified Jablonski diagram.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
        
        <h3 id="sect304"><span class="b_heading">B1. Light</span></h3>
        <span>The use of light in photodynamic therapy has evolved significantly from the use of sunlight to very sophisticated light sources and light delivery tools with the aid of optical technology.<a title="Select to navigate to reference" href="#cit4"><sup><span class="sup_ref">4,13,14</span></sup></a> Light for PDT can be classified into laser and non-laser light sources. Laser light is of a higher quality than the other light sources offering advantages such as high intensity, monochromaticity, no thermal effect by laser (400–800 nm) alone and easy adaptability with fiber optic delivery. Due to the attenuation of incident light by tissue, relatively high fluence rates are required to treat bulky targets. Monochromatic light makes the dosimetry more accurate than non-monochromatic light at least at the surface of the target area. Photofrin® and Visudyne® are approved in combination with laser irradiation (630 and 689 nm, respectively). However, traditional laser systems (<span class="italic">e.g.</span>, argon/<span class="CH"><a class="simple" title="ChEBI Ontology link for: dye" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dye</a></span> or KTP:YAG/<span class="CH"><a class="simple" title="ChEBI Ontology link for: dye" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dye</a></span>) were not readily accessible due to high costs and large size. Diode lasers became more popular in the PDT community solving these problems to some degree. On the other hand, non-coherent light sources offer some advantages over lasers, such as low cost, wide range of <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: spectrum" href="javascript:popupOBO('CMO:0000800','c2ra21404k')">spectrum</a></span>, compact size, easier handling and less regulation. It is advantageous for dermatologic diseases and, in particular, less accurate dosimetric control may be acceptable. A narrow band fluorescence light source (BLU-U®, 400–450 nm) is used for Levulan for acne keratosis. The other type of fluorescence source is available for preclinical applications, such as Lumacare®, where specific filters are used to make narrow band outputs covering a wide range of the spectrum. Recently, light emitting diodes (LEDs) have become readily available for PDT application; they are portable and non-coherent, but adjustable to narrow ranges based on the semiconductor materials. The wavelengths are in the range of 350–1100 nm and can deliver a power output of up to 150 mW cm<small><sup>−2</sup></small>. PDT became more popular and accessible at least in part due to advances in light sources; the availability of good quality light, high power, low cost and customizable delivery using the fibers. It is important to mention that PDT thrives on light wavelengths with excitability in the popularly referred to “therapeutic window” (650 nm–800 nm) for deep tissue penetration. Therefore, designing a light source that excites at a longer wavelength is appropriate for non-invasive PDT treatment. Notable examples of such light sources are 690 nm and 785 nm diode lasers, as well as the variable long wavelength filters (&gt;700 nm) of the Lumacare®.</span>
      
      
        
        <h3 id="sect314"><span class="b_heading">B2. Singlet oxygen – cytotoxic species</span></h3>
        <span>Singlet oxygen has been proven to be the main cytotoxic agent of PDT to cause biological effects among <span class="CH"><a class="simple" title="ChEBI Ontology link for: reactive oxygen species" href="javascript:popupOBO('CHEBI:26523','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26523')">reactive oxygen species</a></span>.<a title="Select to navigate to reference" href="#cit11"><sup><span class="sup_ref">11,15–18</span></sup></a> The production of electronically excited two singlet oxygen states (<small><sup>1</sup></small>Σ<small><sup>+</sup></small><small><sub>g</sub></small> (158 kJ mol<small><sup>−1</sup></small>) and <small><sup>1</sup></small>Δ<small><sub>g</sub></small> (95 kJ mol<small><sup>−1</sup></small>)) above the triplet state oxygen by the quenching of the lowest electronically excited singlet (S<small><sub>1</sub></small>) and triplet (T<small><sub>1</sub></small>) states of substances is possible if the transferred energy is higher than 158 kJ mol<small><sup>−1</sup></small>.<a title="Select to navigate to reference" href="#cit19"><sup><span class="sup_ref">19,20</span></sup></a> The metastable, but reactive O<small><sub>2</sub></small> (<small><sup>1</sup></small>Δ<small><sub>g</sub></small>) can be generated by the deactivation of O<small><sub>2</sub></small> (<small><sup>1</sup></small>Σ<small><sup>+</sup></small><small><sub>g</sub></small>) through electronic and vibrational energy transfer.<a title="Select to navigate to reference" href="#cit19"><sup><span class="sup_ref">19,20</span></sup></a> However, because the lifetime of T<small><sub>1</sub></small> is much longer than S<small><sub>1</sub></small>, it is believed that singlet oxygen (<small><sup>1</sup></small>Δ<small><sub>g</sub></small>) is generated by energy transfer from T<small><sub>1</sub></small> to triplet oxygen.</span>
        <p class="otherpara">Three important aspects of singlet oxygen should be understood for analyzing biological data in PDT. First, the concentration of oxygen, the source of singlet oxygen, may impact on singlet oxygen generation capacity and consequently biological activity. At atmospheric pressure, oxygen concentration in <span class="TC"><a class="simple" title="Chemspider Compound link for:water" target="_blank" href="http://www.chemspider.com/Chemical-Structure.937.html">water</a></span> is about 0.27 mM.<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> Each tissue has a different oxygenation status, <span class="italic">e.g.</span>, pressures of oxygen are 40–100 mmHg in blood and 4–20 mmHg in tissues.<a title="Select to navigate to references" href="#cit22"><sup><span class="sup_ref">22</span></sup></a> In particular, solid tumors is known under a hypoxic condition.<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a> If oxygen concentration is reduced from 5% to 1%, it results in a 50% decrease in PDT effect.<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a> Secondly, the lifetime of singlet oxygen in cells was estimated to be short and singlet oxygen has a limited diffusion distance (10–300 nm).<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24–26</span></sup></a> Thus, singlet oxygen generated in a cell may not directly damage neighboring cells <span class="italic">via</span> diffusion. It has pros and cons in biological implications. It gives PDT an opportunity for highly selective damage to target cells over non-targeted normal cells in the irradiated area. On the other hand, singlet oxygen cannot kill remaining live cells after PDT treatment in the irradiated area, which may arise from the heterogeneity of variables of tumor and PDT, such as PS distribution, oxygen concentration and light intensity.<a title="Select to navigate to reference" href="#cit27"><sup><span class="sup_ref">27–29</span></sup></a> Thirdly, singlet oxygen quantum yield (<span class="italic">Φ</span><small><sub>Δ</sub></small>) is the quantitative expression of a PS's ability to generate singlet oxygen.<a title="Select to navigate to reference" href="#cit30"><sup><span class="sup_ref">30,31</span></sup></a> It has been used as one of the key parameters in assessing the potential of a PS for PDT, which seems reasonable in solution and in mono-layer culture models where the attenuation of the light is minimal. However, the attenuation of incident by tissue is huge.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> Almost 95% <span class="CH"><a class="simple" title="Molecular Process Ontology link for: reduction" href="javascript:popupOBO('MOP:0000569','c2ra21404k')">reduction</a></span> of 690 nm light was observed for thin mouse skin without hair.<a title="Select to navigate to references" href="#cit33"><sup><span class="sup_ref">33</span></sup></a> Light becomes a major limiting factor <span class="italic">in vivo</span>. Thus, a more effective light observer should have a better chance to generate singlet oxygen with limited <span class="CH"><a class="simple" title="ChEBI Ontology link for: photons" href="javascript:popupOBO('CHEBI:30212','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=30212')">photons</a></span>. A better term is needed for estimating the potential of a PS <span class="italic">in vivo</span> accounting for singlet oxygen generation quantum yield in combination with the extinction coefficient (<span class="italic">ε</span>) of the PS at the irradiation wavelength called “phototoxic power” (PP), where PP = <span class="italic">Φ</span><small><sub>Δ</sub></small> × <span class="italic">ε</span>. Although a higher PP does not guarantee the effective <span class="italic">in vivo</span> PDT efficacy due to many other factors involved, it should be a better term than singlet oxygen quantum yield.</p>
      
      
        
        <h3 id="sect370"><span class="b_heading">B3. Photosensitizers</span></h3>
        <span>PSs play a key role in PDT in that it is the <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span> that generates <span class="CH"><a class="simple" title="ChEBI Ontology link for: reactive oxygen species" href="javascript:popupOBO('CHEBI:26523','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26523')">reactive oxygen species</a></span> for cell damage upon light illumination. The report by Jesionek and Von Tappeiner in 1903 on the effect of the topical treatment of tumors with <span class="TC"><a class="simple" title="Chemspider Compound link for:eosin" target="_blank" href="http://www.chemspider.com/Chemical-Structure.10580.html">eosin</a></span> exposed to white light marked one of the milestones in photodynamic events (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3</a>).<a title="Select to navigate to reference" href="#cit34"><sup><span class="sup_ref">34,35</span></sup></a> The extension of photodynamic activity to cancer was initiated by the observation of <span class="CH"><a class="simple" title="ChEBI Ontology link for: porphyrins" href="javascript:popupOBO('CHEBI:26214','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26214')">porphyrins</a></span> in tumors by Polycard in 1924.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> Although several mouse model experiments corroborated the localization of haematoporphyrin and its analogues in tumors,<a title="Select to navigate to references" href="#cit37"><sup><span class="sup_ref">37</span></sup></a> it was not until 1960 that Richard Lipson and co-workers developed the “haematoporphyrin derivative” (HPD), which emitted fluorescence upon localizing in tumors.<a title="Select to navigate to reference" href="#cit38"><sup><span class="sup_ref">38–42</span></sup></a> The treatment of mammary tumors <span class="italic">in vivo</span> with HPD and red light by Dougherty and his colleagues made a major transformation in photodynamic effects.<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a> Subsequently, Kelly and Snell performed the first human treatment with HPD for bladder cancer.<a title="Select to navigate to reference" href="#cit44"><sup><span class="sup_ref">44,45</span></sup></a> Several preclinical and clinical trials of HPD and purified HPD led to its approval under the trade name <span class="TC"><a class="simple" title="Chemspider Compound link for:Photofrin" target="_blank" href="http://www.chemspider.com/Chemical-Structure.10482043.html">Photofrin</a></span> for photodynamic therapy treatment of Barrett's oesophagus, cervical cancer, endobroncheal cancer, oesaphageal cancer, gastric cancer and papillary bladder cancer in a number of countries. <span class="TC"><a class="simple" title="Chemspider Compound link for:Photofrin" target="_blank" href="http://www.chemspider.com/Chemical-Structure.10482043.html">Photofrin</a></span> induces phototoxicity through a cellular uptake mechanism, relying on intracellular oxygen levels. Photofrin-PDT cell death phenotype has been found to be largely dependent on the subcellular localization of <span class="TC"><a class="simple" title="Chemspider Compound link for:Photofrin" target="_blank" href="http://www.chemspider.com/Chemical-Structure.10482043.html">Photofrin</a></span>.<a title="Select to navigate to references" href="#cit46"><sup><span class="sup_ref">46</span></sup></a></span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><img alt="Milestones of photosensitizers in PDT." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f3.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">Milestones of photosensitizers in PDT.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The development of efficient PSs led to the second-generation PSs to overcome the problems of <span class="TC"><a class="simple" title="Chemspider Compound link for:Photofrin" target="_blank" href="http://www.chemspider.com/Chemical-Structure.10482043.html">Photofrin</a></span>, such as chemical complexity, skin photosensitization and short tissue penetration due to absorption at 630 nm with a small extinction coefficient. The quest for more ideal PSs has opened the door to several <span class="CH"><a class="simple" title="ChEBI Ontology link for: porphyrin" href="javascript:popupOBO('CHEBI:26214','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26214')">porphyrin</a></span>-based, as well as non-porphyrin-based PSs.<a title="Select to navigate to reference" href="#cit47"><sup><span class="sup_ref">47–53</span></sup></a> Second-generation PSs satisfy fully or partially the following criteria: chemically defined structure (<span class="italic">i.e.</span> pure compound), effective singlet oxygen generation, absorption at photodynamic window (650–800 nm), low dark but high phototoxicity, good photostability and low skin photosensitization <span class="italic">in vivo</span>.</p>
        <p class="otherpara">More recent PSs have been designed to achieve 1) absorption and emission near 800 nm with high efficiencies, 2) improved specificity to targets using targeting vectors or target-specific <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: activation" href="javascript:popupOBO('CMO:0002196','c2ra21404k')">activation</a></span> mechanisms and 3) dual modality for imaging and therapy.<a title="Select to navigate to reference" href="#cit54"><sup><span class="sup_ref">54–58</span></sup></a> Stable <span class="CH"><a class="simple" title="ChEBI Ontology link for: bacteriochlorin" href="javascript:popupOBO('CHEBI:52581','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=52581')">bacteriochlorin</a></span>-based PSs have been extensively studied for absorption near 800 nm with high extinction coefficient.<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a> <span class="CH"><a class="simple" title="ChEBI Ontology link for: Palladium" href="javascript:popupOBO('CHEBI:33364','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33364')">Palladium</a></span>-bacteriopheophorbide (TOOKAD), derived from the natural bacteriochlorophyl a, can be excited at 763 nm with a high extinction coefficient (∼100<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000 M<small><sup>−1</sup></small> cm<small><sup>−1</sup></small>). Notably, it has been studied specifically for anti-vascular PDT while most of photosensitizers are known to induce three mechanisms: direct cell damage, immunolgical effect, and anti-vascular effect. TOOKAD, in fact, made a significant progress to clinical trials.<a title="Select to navigate to references" href="#cit59"><sup><span class="sup_ref">59</span></sup></a> Traditionally, PSs have been known to be specific to tumors with unknown mechanisms. However, improved delivery has been sought by using targeting vectors, such as <span class="CH"><a class="simple" title="ChEBI Ontology link for: ligands" href="javascript:popupOBO('CHEBI:52214','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=52214')">ligands</a></span>, <span class="CH"><a class="simple" title="ChEBI Ontology link for: peptides" href="javascript:popupOBO('CHEBI:16670','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=16670')">peptides</a></span> and antibodies.<a title="Select to navigate to reference" href="#cit56"><sup><span class="sup_ref">56,60–63</span></sup></a> Active investigations have also been taking place for developing activatable PSs that can be transformed to the active form from the deactivated form by internal or external stimuli for improved target specificity.<a title="Select to navigate to references" href="#cit58"><sup><span class="sup_ref">58</span></sup></a> The unique procedure for PDT, <span class="italic">i.e.</span> light-activation, made it very attractive for developing theranostic applications: therapy and diagnostics.<a title="Select to navigate to reference" href="#cit63"><sup><span class="sup_ref">63,64</span></sup></a> Various imaging modalities can be combined with PDT, such as MRI, <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: fluorescence imaging" href="javascript:popupOBO('CMO:0000087','c2ra21404k')">fluorescence imaging</a></span>, PET, <span class="italic">etc.</span> In particular, the combination of PDT and <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: fluorescence imaging" href="javascript:popupOBO('CMO:0000087','c2ra21404k')">fluorescence imaging</a></span> can offer a more effective management option for certain types of cancer.<a title="Select to navigate to reference" href="#cit57"><sup><span class="sup_ref">57,65–67</span></sup></a></p>
      
    
    
      
      <h2 id="sect417"><span class="a_heading">C. History of BODIPY-based photosensitizers</span></h2>
      <span>The BODIPY-based PSs are dipyrrole units connected by a methine (<span class="italic">i.e.</span> carbon atom at the <span class="italic">meso</span> position) or an aza-methine unit (<span class="italic">i.e.</span> <span class="CH"><a class="simple" title="ChEBI Ontology link for: nitrogen atom" href="javascript:popupOBO('CHEBI:25555','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=25555')">nitrogen atom</a></span> at the <span class="italic">meso</span> position) in a tricyclic fusion – a six membered ring with a boron center to constrain the structure flanked by two five-membered units. The Burgess group,<a title="Select to navigate to references" href="#cit8"><sup><span class="sup_ref">8</span></sup></a> as well as Ziessel <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit68"><sup><span class="sup_ref">68</span></sup></a> produce sterling information on the chemistry, synthesis, reactivity, chemical modification of BODIPY-based compounds and spectral details in their reviews. The boron dipyrromethene has inherent fluorescent properties with excellent optical properties, such as intense fluorescence quantum yields, sharp excitation and <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: emission spectra" href="javascript:popupOBO('CMO:0000813','c2ra21404k')">emission spectra</a></span>, highly photo- and chemo-stablity<a title="Select to navigate to reference" href="#cit69"><sup><span class="sup_ref">69,70</span></sup></a> and usablity in both lipophilic and aqueous media.<a title="Select to navigate to reference" href="#cit67"><sup><span class="sup_ref">67,68</span></sup></a> The aza-BODIPY was first synthesized by Rogers in 1943 as a coloring agent,<a title="Select to navigate to reference" href="#cit71"><sup><span class="sup_ref">71,72</span></sup></a> while in the late 1960s work by Treibs and Kruezer discovered the famous 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY).<a title="Select to navigate to references" href="#cit73"><sup><span class="sup_ref">73</span></sup></a> It was not until 2002 that O'Shea and co-workers published their findings on a structurally constrained aza-BODIPY and its application for photodynamic therapy. Their work gave an evidence of a new class of non-porphyrinic photodynamic therapy agent as they assessed the spectroscopic, photophysical and <span class="italic">in vitro</span> cellular uptake of the sensitizers.<a title="Select to navigate to references" href="#cit74"><sup><span class="sup_ref">74</span></sup></a> The group expanded their efforts to demonstrate the first <span class="italic">in vitro</span> and <span class="italic">in vivo</span> photodynamic action with a new class of aza-BODIPY PSs. In 2005, Nagano <span class="italic">et al.</span> showed the conversion of the highly fluorescent BODIPY into a potent PS with its excellent optical properties being maintained through the heavy atom effect.<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a> In 2009, O'Shea and co-workers published <span class="italic">in vivo</span> studies using aza-BODIPY-based <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span>.<a title="Select to navigate to references" href="#cit76"><sup><span class="sup_ref">76</span></sup></a></span>
    
    
      
      <h2 id="sect443"><span class="a_heading">D. Characteristics of the <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY compound" href="javascript:popupOBO('CHEBI:51108','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51108')">BODIPY compound</a></span></span></h2>
      <span>The BODIPY framework is known to be a versatile and robust fluorophore due to its numerous useful applications. In fact, the use of BODIPY for biological <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: labeling" href="javascript:popupOBO('CMO:0001675','c2ra21404k')">labeling</a></span> <span class="italic">via</span> fluorescent conjugates of <span class="CH"><a class="simple" title="ChEBI Ontology link for: proteins" href="javascript:popupOBO('CHEBI:36080','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=36080')">proteins</a></span>, <span class="CH"><a class="simple" title="ChEBI Ontology link for: nucleotides" href="javascript:popupOBO('CHEBI:36976','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=36976')">nucleotides</a></span>, <span class="CH"><a class="simple" title="ChEBI Ontology link for: fatty acids" href="javascript:popupOBO('CHEBI:35366','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=35366')">fatty acids</a></span> and other biological units to understand biological systems and pathways makes it a photostable substitute for <span class="TC"><a class="simple" title="Chemspider Compound link for:fluorescein" target="_blank" href="http://www.chemspider.com/Chemical-Structure.15968.html">fluorescein</a></span> and rhodamine among others.<a title="Select to navigate to references" href="#cit68"><sup><span class="sup_ref">68</span></sup></a> BODIPY can be tuned from wavelengths (excitation and emission) of about ∼500 nm to NIR wavelengths by structural modification with sharp absorption and emission bands. In addition to the flexible synthesis, several photophysical properties, such as singlet–triplet state character and electrochemical properties, can be tuned as desired. These properties have enabled the transformation of a <span class="CH"><a class="simple" title="ChEBI Ontology link for: fluorescent dye" href="javascript:popupOBO('CHEBI:51121','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51121')">fluorescent dye</a></span> with negligible triplet state to a PS. A notable deficiency of most BODIPY PSs developed so far has been their excitability in the region of ∼500 nm, which renders them short of the therapeutic window (650–800 nm) for effective <span class="italic">in vivo</span> application. This has prompted the development of longer wavelength BODIPYs, as will be discussed later in this review.</span>
    
    
      
      <h2 id="sect457"><span class="a_heading">E. Structural modification of BODIPY-based photosensitizers and the heavy atom effect</span></h2>
      
        
        <h3 id="sect460"><span class="b_heading">E1. <span class="CH"><a class="simple" title="Molecular Process Ontology link for: Halogenation" href="javascript:popupOBO('MOP:0000550','c2ra21404k')">Halogenation</a></span> and the heavy atom effect</span></h3>
        <span>The mesomeric structures of BODIPY show that its 2- and 6- positions are prone to electrophilic substitution, as typified by Treibs and Kreuzer in the use of <span class="TC"><a class="simple" title="Chemspider Compound link for:chlorosulfonic acid" target="_blank" href="http://www.chemspider.com/Chemical-Structure.23040.html">chlorosulfonic acid</a></span> for sulfonation.<a title="Select to navigate to references" href="#cit73"><sup><span class="sup_ref">73</span></sup></a> The electronic-rich property possessed by the BODIPY core makes it useful for chemical modification, especially the electrophilic aromatic substitution with <span class="CH"><a class="simple" title="ChEBI Ontology link for: halogens" href="javascript:popupOBO('CHEBI:24473','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=24473')">halogens</a></span> (Br, I), which converts the highly fluorescent or low triplet transition molecule to a potent PS with efficient intersystem crossing capacity due to spin orbit coupling by the heavy atom effect. The heavy atom effect may be described as the enhancement of a spin-forbidden process induced by the presence of an atom of a high atomic number, either internal or external to the excited molecule.<a title="Select to navigate to references" href="#cit77"><sup><span class="sup_ref">77</span></sup></a></span>
        <div>
          
          <span id="sect469"/><span class="c_heading_indent">E1.1. Bromination. </span>
          <span><span class="CH"><a class="simple" title="Molecular Process Ontology link for: Bromination" href="javascript:popupOBO('MOP:0000551','c2ra21404k')">Bromination</a></span> has been explored and proved useful (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>). Di-bromination of 1,3,5,7-tetraalkyl substituted and 1,3,5,7,8-pentalkyl BODIPY was achieved through the free radical-type halogenation approach using <span class="italic">N</span>-bromosuccinamide (NBS) and AIBN in carbon tetrachloride for 30–40 min.<a title="Select to navigate to reference" href="#cit78"><sup><span class="sup_ref">78–80</span></sup></a> Recently, Shinokubo <span class="italic">et al.</span> demonstrated a regioselective bromination of 1,3,5,7- unsubstituted BODIPY using 1.2 and 2.4 equivalents of NBS in CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small> at room temperature to achieve mono- and di-brominated forms, respectively.<a title="Select to navigate to references" href="#cit81"><sup><span class="sup_ref">81</span></sup></a> Pavlopoulos <span class="italic">et al.</span> used molecular bromine in <span class="TC"><a class="simple" title="Chemspider Compound link for:benzene" target="_blank" href="http://www.chemspider.com/Chemical-Structure.236.html">benzene</a></span> or <span class="TC"><a class="simple" title="Chemspider Compound link for:dichloromethane" target="_blank" href="http://www.chemspider.com/Chemical-Structure.6104.html">dichloromethane</a></span> to obtain di-brominated products.<a title="Select to navigate to references" href="#cit82"><sup><span class="sup_ref">82</span></sup></a> The latter approach has been used extensively in the bromination of aza-BODIPY analogues.<a title="Select to navigate to reference" href="#cit74"><sup><span class="sup_ref">74,83</span></sup></a> Excited state investigation of the brominated BF2-azadipyrromethene displays a quenched nanosecond NIR fluorescence leading to a 21 μs transient absorption peak. The efficient triplet state population of about 72% due to the bromine-induced heavy atom effect leads to singlet oxygen formation of ∼74%.<a title="Select to navigate to references" href="#cit84"><sup><span class="sup_ref">84</span></sup></a> A stepwise electrophilic <span class="CH"><a class="simple" title="Molecular Process Ontology link for: bromination" href="javascript:popupOBO('MOP:0000551','c2ra21404k')">bromination</a></span> of unsubstituted BODIPY was achieved by bromine in a regioselective fashion to obtain mono- to hepta-bromo BODIPY in good to excellent yields (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1d</a>).<a title="Select to navigate to references" href="#cit85"><sup><span class="sup_ref">85</span></sup></a> Most recently, Hu <span class="italic">et al.</span> also reported stepwise <span class="CH"><a class="simple" title="Molecular Process Ontology link for: bromination" href="javascript:popupOBO('MOP:0000551','c2ra21404k')">bromination</a></span> of BODIPY (<strong>16</strong>) using benzyl triethyl ammonium perbromide (<strong>15</strong>) (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1e</a>).<a title="Select to navigate to references" href="#cit86"><sup><span class="sup_ref">86</span></sup></a></span>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><img alt="Bromination reactions of BODIPY." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-s1.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Bromination reactions of BODIPY.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch2"><img alt="Regioselective bromination of the pentacyclic BODIPY core." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-s2.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 2 </b> <span id="sch2"><span class="graphic_title">Regioselective <span class="CH"><a class="simple" title="Molecular Process Ontology link for: bromination" href="javascript:popupOBO('MOP:0000551','c2ra21404k')">bromination</a></span> of the pentacyclic BODIPY core.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">You <span class="italic">et al.</span>, in an attempt to obtain long wavelength PSs, employed the bromination of highly conjugated BODIPY systems using bromine with trace iodine in CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>. This <span class="CH"><a class="simple" title="Molecular Process Ontology link for: bromination" href="javascript:popupOBO('MOP:0000551','c2ra21404k')">bromination</a></span> approach was selective in generating di- (<strong>22</strong> and <strong>23</strong>) and tetra- (<strong>24</strong> and <strong>25</strong>) brominated forms.<a title="Select to navigate to references" href="#cit87"><sup><span class="sup_ref">87</span></sup></a></p>
        </div>
        <div>
          
          <span id="sect512"/><span class="c_heading_indent">E1.2. Iodination. </span>
          <span>Iodine, a heavier atom than bromine, also exerts the heavy atom effect resulting in effective singlet to triplet transition and is hence valuable in the synthesis and design of PSs. Nagano <span class="italic">et al.</span> demonstrated the use of iodine by synthesizing 2,6-diiodo-tetramethyl BODIPY, <strong>27</strong>.<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a> The incorporation of iodine causes a significant bathochromic shift of absorption maxima in ∼30 nm. Various polyiodinated BODIPY analogues were prepared by Ortiz <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit88"><sup><span class="sup_ref">88</span></sup></a> They demonstrated that varying degrees of <span class="CH"><a class="simple" title="Molecular Process Ontology link for: iodination" href="javascript:popupOBO('MOP:0000554','c2ra21404k')">iodination</a></span> can be achieved and the iodination improved the singlet oxygen generation. Tetra-iodinated BODIPY <strong>28</strong> showed about 87% of singlet oxygen quantum yield compared to Rose Bengal (71%). The introduction of iodine atoms in the pyrrole ring of aza-BODIPY derivatives also improved the intersystem crossing efficiency, which was prepared by reacting <strong>29</strong> (long wavelength) with 4.5 equiv of <span class="TC"><a class="simple" title="Chemspider Compound link for:N-iodosuccinimide" target="_blank" href="http://www.chemspider.com/Chemical-Structure.107372.html"><span class="italic">N</span>-iodosuccinimide</a></span> in a 3<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 mixture of <span class="TC"><a class="simple" title="Chemspider Compound link for:chloroform" target="_blank" href="http://www.chemspider.com/Chemical-Structure.5977.html">chloroform</a></span>/<span class="TC"><a class="simple" title="Chemspider Compound link for:acetic acid" target="_blank" href="http://www.chemspider.com/Chemical-Structure.171.html">acetic acid</a></span> at 25 °C for 10 h.<a title="Select to navigate to reference" href="#cit89"><sup><span class="sup_ref">89,90</span></sup></a></span>
        </div>
      
      
        
        <h3 id="sect529"><span class="b_heading">E2. Short wavelength BODIPY Photosensitizer</span></h3>
        <span>In this section, we focus on BODIPYs that absorb &lt;600 nm, referred to as short wavelength PSs. The practical use of these PSs absorbing shorter wavelengths than the photodynamic window may be limited, especially for the treatment of solid tumors. Structural variations influence the efficacy of the BODIPY family of compounds for use as potent PSs. These short wavelength BODIPYs were synthesized in about 3–4 steps and maintained some of the original photophysical characteristics of its parent BODIPY fluorophore, such as absorption and emission maxima, sharp absorption and emission peaks. Early BODIPY-based <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> development, like all other classes of PSs and general <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span> development, focused on generating efficient PSs with high singlet oxygen quantum yield before further modifications for improving biological activity.</span>
        <p class="otherpara">The <span class="CH"><a class="simple" title="Molecular Process Ontology link for: iodination" href="javascript:popupOBO('MOP:0000554','c2ra21404k')">iodination</a></span> of the highly fluorescent <strong>26</strong> generates a PS (<strong>27</strong>) of singlet oxygen quantum yield ∼ 1 with exceptional photostable properties (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3a</a>).<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a><span class="italic">In vitro</span> photosensitization of <strong>27</strong> was determined by loading HeLa cells with 1 μM for 30 min and irradiation with green light (535 ± 25 nm, 5 mW cm<small><sup>−2</sup></small>) for 1 min under a fluorescence microscope with a concurrent cell viability assay through the use of esterase and nucleic acid intercalating <span class="CH"><a class="simple" title="ChEBI Ontology link for: dyes" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dyes</a></span>, <span class="TC"><a class="simple" title="Chemspider Compound link for:calcein" target="_blank" href="http://www.chemspider.com/Chemical-Structure.58589.html">calcein</a></span> AM and ethidium homodimer-1 (EthD-1). Phototoxicity was observed, proposing <strong>27</strong> to be a useful agent for PDT (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4</a>). Phototoxicity of <strong>27</strong> against 3 different cell lines was also determined by another group: promyelocytic leukemia cell line (HL-60), oral squamous carcinoma cell line (HSC-2) and nasopharyngeal carcinoma cell line (HK1) following irradiation with 4.1 J cm<small><sup>−2</sup></small> broadband light yielded IC<small><sub>50</sub></small> values of 0.062 μM, 0.64 μM and 0.57 μM, respectively.<a title="Select to navigate to references" href="#cit91"><sup><span class="sup_ref">91</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><img alt="Cell photosensitization by 27 (2I-BDP). (A–C) Differential interference contrast (DIC) and fluorescence images of HeLa cells loaded with calcein AM (living cell marker) and EthD-1 (dead cell marker) after photosensitization with 27. (D–F) Loading with 27 alone had no toxic effect in this assay. Reprinted with permission from ref. 70. Copyright 2005 American Chemical Society." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f4.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Cell photosensitization by <strong>27</strong> (2I-BDP). (A–C) Differential interference contrast (<span class="CH"><a class="simple" title="Chemical Methods Ontology link for: DIC" href="javascript:popupOBO('CMO:0000107','c2ra21404k')">DIC</a></span>) and fluorescence images of HeLa cells loaded with <span class="TC"><a class="simple" title="Chemspider Compound link for:calcein" target="_blank" href="http://www.chemspider.com/Chemical-Structure.58589.html">calcein</a></span> AM (living cell marker) and EthD-1 (dead cell marker) after photosensitization with <strong>27</strong>. (D–F) Loading with <strong>27</strong> alone had no toxic effect in this assay. Reprinted with permission from <a title="Select to navigate to references" href="#cit70">ref. 70</a>. Copyright 2005 American Chemical Society.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch3"><img alt="Iodination of BODIPY and aza-BODIPY." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-s3.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 3 </b> <span id="sch3"><span class="graphic_title"><span class="CH"><a class="simple" title="Molecular Process Ontology link for: Iodination" href="javascript:popupOBO('MOP:0000554','c2ra21404k')">Iodination</a></span> of BODIPY and aza-BODIPY.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Lee <span class="italic">et al.</span> investigated the structural implications on cell phototoxicity of 15 BODIPY analogues.<a title="Select to navigate to references" href="#cit91"><sup><span class="sup_ref">91</span></sup></a> The study involved functionalization by <span class="CH"><a class="simple" title="Molecular Process Ontology link for: iodination" href="javascript:popupOBO('MOP:0000554','c2ra21404k')">iodination</a></span> at 2- and 6- positions, <span class="italic">meso</span>-substitution with iodophenyl and alkylcarboxylic acid, direct sulphonation at the 2,6-positions to improve the hydrophilicity and extended conjugation using fragments such as <span class="TC"><a class="simple" title="Chemspider Compound link for:acrylic acid" target="_blank" href="http://www.chemspider.com/Chemical-Structure.6333.html">acrylic acid</a></span>, ethenesulphonic acid and <span class="TC"><a class="simple" title="Chemspider Compound link for:methyl acrylate" target="_blank" href="http://www.chemspider.com/Chemical-Structure.7022.html">methyl acrylate</a></span>. Among the four iodinated analogues (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5a</a>), compound <strong>34</strong> shows potent photodynamic activity and is an attractive lead photochemotherapeutic agent owing to its facile synthesis with attendant incorporation of a carboxylic fragment for functionalization, which is useful in the attachment of targeting moieties. The synthesis relied on the incorporation of alkylcarboxylate functionality by the use of <span class="CH"><a class="simple" title="ChEBI Ontology link for: carboxylic anhydride" href="javascript:popupOBO('CHEBI:35873','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=35873')">carboxylic anhydride</a></span> in a one-pot process (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5b</a>), as earlier reported by Wang <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit92"><sup><span class="sup_ref">92</span></sup></a> and Li <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit93"><sup><span class="sup_ref">93</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><img alt="(a) Iodinated BODIPY PSs and (b) the synthetic scheme for 34." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f5.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">(a) Iodinated BODIPY PSs and (b) the synthetic scheme for <strong>34</strong>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The intracellular accumulation of <strong>34</strong> loaded on the HSC-2 cell line as displayed in the co-staining of <strong>34</strong> and rhodamine 123 (mitochondria-specific <span class="CH"><a class="simple" title="ChEBI Ontology link for: dye" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dye</a></span>) by <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: spinning" href="javascript:popupOBO('CMO:0001618','c2ra21404k')">spinning</a></span> disk <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: confocal microscopy" href="javascript:popupOBO('CMO:0000103','c2ra21404k')">confocal microscopy</a></span> exhibits particular localization in the mitochondria (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6a</a>) over the endoplasmic reticulum and lysosome using ER tracker and Lysotracker, respectively (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6b and c</a>). Compound <strong>34</strong> also induced apoptosis. In addition, an anti-angiogenic PDT effect was observed in the CAM assay (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6d</a>). The well-vascularized chick chorioallantoic membrane (CAM) as the main respiratory organ of the chick embryo has shown to be an adaptive model for the studies of vascular damage in PDT.<a title="Select to navigate to reference" href="#cit94"><sup><span class="sup_ref">94,95</span></sup></a> The ability of <strong>34</strong> to impose vasculature disruption using 3.5–7.0 nmol/embryo with a light dose of 20–40 J cm<small><sup>−2</sup></small> is appreciable. The results show a dependence of vascular damage on <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span>-light doses with controls showing no damage. Since the anti-angiogenic effect is one of the three main mechanisms for anti-tumor PDT effects, along with direct cell killing and immunological effects, this compound has the potential to be a PS for anti-tumor PDT.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><img alt="Intracellular localization of compound 34 (= compound 5 in (d)): spinning disk confocal images (a, b, c) of HSC-2 cells double-stained with 100 nM 34 and respective organelle probes. (a) Mitochondria (100 nM Rh123), (b) endoplasmic reticulum (100 nM ER-Tracker) and (c) lysosomes (500nM LysoTracker). Objective magnification is 63. (d) Representative angiographs of blood vessels supplying the CAM at the beginning and 24 h after PDT, illustrating the vascular occlusion efficacy induced by compound 5 at 3.5–7 nmol/embryo: irradiation at 510–560 nm of 20–40 J cm−2). Objective magnification is 4. Adopted with permission from ref. 84. Copyright 2010 American Chemical Society." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f6.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title">Intracellular localization of compound <strong>34</strong> (= compound <span class="bold">5</span> in (d)): <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: spinning" href="javascript:popupOBO('CMO:0001618','c2ra21404k')">spinning</a></span> disk confocal images (a, b, c) of HSC-2 cells double-stained with 100 nM <strong>34</strong> and respective organelle probes. (a) Mitochondria (100 nM Rh123), (b) endoplasmic reticulum (100 nM ER-Tracker) and (c) lysosomes (500nM LysoTracker). Objective magnification is 63. (d) Representative angiographs of blood vessels supplying the CAM at the beginning and 24 h after PDT, illustrating the vascular occlusion efficacy induced by compound 5 at 3.5–7 nmol/embryo: irradiation at 510–560 nm of 20–40 J cm<small><sup>−2</sup></small>). Objective magnification is 4. Adopted with permission from <a title="Select to navigate to references" href="#cit84">ref. 84</a>. Copyright 2010 American Chemical Society.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect604"><span class="b_heading">E3. Long wavelength BODIPY-based photosensitizers</span></h3>
        <span>The development of <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span> absorbing/emitting in the far-red/near infrared region of the electromagnetic spectrum has attracted enormous research attention in recent years due to numerous advantages, especially in its biological application both in <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: fluorescence imaging" href="javascript:popupOBO('CMO:0000087','c2ra21404k')">fluorescence imaging</a></span> and PDT. Between 700–900 nm, absorption by cells/tissues and <span class="TC"><a class="simple" title="Chemspider Compound link for:water" target="_blank" href="http://www.chemspider.com/Chemical-Structure.937.html">water</a></span>, light scattering and autofluorescence is reduced significantly, allowing for deeper light penetration, resulting in efficient therapy and diagnosis.<a title="Select to navigate to references" href="#cit96"><sup><span class="sup_ref">96</span></sup></a> Thus, significant research effort has been made to generate BODIPY fluorophores absorbing at longer wavelength, &gt;700 nm. It is important to mention that the strategies for BODIPY PSs absorbing in the far-red or NIR region rely heavily on its BODIPY fluorophore counterparts; hence the need to outline some of these fundamental approaches used for the <span class="CH"><a class="simple" title="ChEBI Ontology link for: fluorochromes" href="javascript:popupOBO('CHEBI:51217','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51217')">fluorochromes</a></span>. The following strategies can be used to induce bathochromic shift of <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span> (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7</a>). 1) <span class="CH"><a class="simple" title="ChEBI Ontology link for: Aryl" href="javascript:popupOBO('CHEBI:33338','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33338')">Aryl</a></span> substitution at the 1,3,5 and 7-positions of the BODIPY core induce the red-shift.<a title="Select to navigate to reference" href="#cit97"><sup><span class="sup_ref">97,98</span></sup></a> 2) <span class="CH"><a class="simple" title="ChEBI Ontology link for: Vinyl" href="javascript:popupOBO('CHEBI:37603','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37603')">Vinyl</a></span> substitution at the 2,6-positions with respective acrylate moieties (20–25) <span class="italic">via</span> <span class="CH"><a class="simple" title="ChEBI Ontology link for: palladium" href="javascript:popupOBO('CHEBI:33364','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33364')">palladium</a></span>-catalyzed C–H functionalization in the Heck-type reaction<a title="Select to navigate to references" href="#cit99"><sup><span class="sup_ref">99</span></sup></a> red shifts by about 20–30 nm with monosubstitution and 50–60 nm with bis-substitution. Ethynylaryl substitution at the 3,5-positions of the BODIPY core is also an appealing approach to promote red shifting. The <span class="CH"><a class="simple" title="RXNO Ontology link for: Sonogashira reaction" href="javascript:popupOBO('RXNO:0000137','c2ra21404k')">Sonogashira reaction</a></span> using arylacetylene with its corresponding <span class="CH"><a class="simple" title="ChEBI Ontology link for: halogen" href="javascript:popupOBO('CHEBI:24473','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=24473')">halogen</a></span>-substituted BODIPY makes it possible.<a title="Select to navigate to reference" href="#cit100"><sup><span class="sup_ref">100,101</span></sup></a> 3) In some cases, the Liebeskind–Srogl coupling with <span class="CH"><a class="simple" title="ChEBI Ontology link for: boronic acids" href="javascript:popupOBO('CHEBI:38269','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=38269')">boronic acids</a></span> or tin-based compounds<a title="Select to navigate to references" href="#cit102"><sup><span class="sup_ref">102</span></sup></a> and nucleophilic substitution of <span class="CH"><a class="simple" title="ChEBI Ontology link for: halogen" href="javascript:popupOBO('CHEBI:24473','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=24473')">halogen</a></span>-substituted BODIPY at the 3,5-positions with conjugated groups induces red shifting.<a title="Select to navigate to reference" href="#cit85"><sup><span class="sup_ref">85,103</span></sup></a> 4) A popular approach used to date to obtain long-wavelength BODIPY PSs is the styryl substitution by Knoevanegel condensation. The versatility of the styryl substitution is unsurpassed<a title="Select to navigate to reference" href="#cit104"><sup><span class="sup_ref">104,105</span></sup></a> in that it occurs in moderate yields and can be achieved in a stepwise fashion from monosubstituted to even tetrasubstitution with a corresponding red-shift.<a title="Select to navigate to references" href="#cit106"><sup><span class="sup_ref">106</span></sup></a> Akkaya and co-workers make a sterling observation in the assessment of the acidity of <span class="CH"><a class="simple" title="ChEBI Ontology link for: methyl" href="javascript:popupOBO('CHEBI:32875','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=32875')">methyl</a></span> <span class="CH"><a class="simple" title="ChEBI Ontology link for: protons" href="javascript:popupOBO('CHEBI:24636','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=24636')">protons</a></span> in a tetramethyl-BODIPY, indicating electron densities in the order 2,6 ≫ 1,7 &gt; 3,5.<a title="Select to navigate to references" href="#cit106"><sup><span class="sup_ref">106</span></sup></a> The methyl groups in positions 1 and 7 may be similar in acidity to that of 3,5 methyl groups. 5) Using aromatic ring fusion and extended aromatic systems is an intelligent approach to obtain long wavelength <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span> by extended conjugation. Chemical modification in this regard could be achieved <span class="italic">via</span> benzo-fusion following the retro-Diels–Alder reaction of norbornane-derived <span class="CH"><a class="simple" title="ChEBI Ontology link for: pyrroles" href="javascript:popupOBO('CHEBI:26455','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26455')">pyrroles</a></span> by Ono and co workers.<a title="Select to navigate to reference" href="#cit107"><sup><span class="sup_ref">107–110</span></sup></a> A facile method to obtain functionalized asymmetric benzo-fused BODIPY has been proposed by Hao <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit111"><sup><span class="sup_ref">111</span></sup></a> <span class="CH"><a class="simple" title="ChEBI Ontology link for: Heteroaryl" href="javascript:popupOBO('CHEBI:33470','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33470')">Heteroaryl</a></span> fusion is attractive due to the bathochromic shift in the absorption and emission maxima it induces, as well as enhanced molar absorption. 6) In addition to the extensive π-system it imposes, it retains a rigidified and high planarity BODIPY <span class="CH"><a class="simple" title="ChEBI Ontology link for: chromophore" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">chromophore</a></span>, which directly affect the photophysical properties. Suzuki <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit70"><sup><span class="sup_ref">70</span></sup></a> and You <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit87"><sup><span class="sup_ref">87</span></sup></a> demonstrated the <span class="CH"><a class="simple" title="ChEBI Ontology link for: heteroaryl" href="javascript:popupOBO('CHEBI:33470','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33470')">heteroaryl</a></span> ring fusion using <span class="TC"><a class="simple" title="Chemspider Compound link for:furan" target="_blank" href="http://www.chemspider.com/Chemical-Structure.7738.html">furan</a></span> and <span class="TC"><a class="simple" title="Chemspider Compound link for:thiophene" target="_blank" href="http://www.chemspider.com/Chemical-Structure.7739.html">thiophene</a></span> at the C-2/C-3 and C-5/C-6 positions, respectively. 7) To further induce bathochromic shifting of absorption and emission maxima into the NIR region, incorporation of electron-donating (HOMO) and electron withdrawing (LUMO) moieties in a D–π–A fashion is useful – a common color chemistry phenomenon.<a title="Select to navigate to references" href="#cit112"><sup><span class="sup_ref">112</span></sup></a> 8) The replacement of the <span class="italic">meso</span>-carbon with a N atom, as reflected in aza-BODIPY <span class="CH"><a class="simple" title="ChEBI Ontology link for: dyes" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dyes</a></span>, is a proven strategy for long-wavelength BODIPYs. The lone pair electrons on the <span class="CH"><a class="simple" title="ChEBI Ontology link for: nitrogen atom" href="javascript:popupOBO('CHEBI:25555','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=25555')">nitrogen atom</a></span> engineer a reduced HOMO–LUMO gap by interfering with the orbital architecture of the <span class="CH"><a class="simple" title="ChEBI Ontology link for: pyrroles" href="javascript:popupOBO('CHEBI:26455','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26455')">pyrroles</a></span>, hence, the bathochromic shift.<a title="Select to navigate to references" href="#cit113"><sup><span class="sup_ref">113</span></sup></a> The aza-BODIPY analogues, ADPM06, in PDT have shown great promise with their far-red absorption being a strong selling point. 9) It is worth noting that constraining or rigidifying rotatory moieties can also induce red shifting.<a title="Select to navigate to reference" href="#cit74"><sup><span class="sup_ref">74,114</span></sup></a> Overall, an extended π-system with simultaneous retention of the molecule's rigidity and increased planarity promote long-wavelength <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span>. A highly functionalized, water-soluble long-wavelength BODIPY <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> still remains a challenge to circumvent.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig7"><img alt="A schematic summary of chemical modification for long-wavelength BODIPY dyes." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f7.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 7 </b> <span id="fig7"><span class="graphic_title">A schematic summary of chemical modification for long-wavelength <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect660"><span class="b_heading">E3.1. Styryl/<span class="TC"><a class="simple" title="Chemspider Compound link for:Distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">Distyryl</a></span> BODIPY-based photosensitizers</span></h3>
        <span>The styryl group incorporation provides a red-shift to approximately 100 nm (<span class="italic">i.e.</span> ∼600 nm absorption maxima)<a title="Select to navigate to references" href="#cit115"><sup><span class="sup_ref">115</span></sup></a> with further red shifting obtained with the introduction of a second styryl group (<span class="italic">i.e.</span> ∼680 nm).<a title="Select to navigate to references" href="#cit113"><sup><span class="sup_ref">113</span></sup></a> The styryl incorporation by the Knoevanegel condensation into the BODIPY core can be achieved symmetrically and/or unsymmetrically without compromising the excellent photophysical properties possessed by <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span>. The introduction of functionalized styryl and distyryl groups with water-soluble moieties, such as pegylated structures, enhanced biocompatibility, hydrophilicity and cellular uptake. Akkaya <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit116"><sup><span class="sup_ref">116</span></sup></a> and Ng <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit117"><sup><span class="sup_ref">117</span></sup></a> showed the <span class="italic">in vitro</span> localization and photocytotoxicity of water-soluble and symmetrical <span class="TC"><a class="simple" title="Chemspider Compound link for:distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">distyryl</a></span> BODIPY PSs (<a title="Select to navigate to figure" href="#imgfig8">Fig. 8a and b</a>).<a title="Select to navigate to reference" href="#cit116"><sup><span class="sup_ref">116,117</span></sup></a> The <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> design possessed a heavy atom (bromine/iodine) substituted at the 2,6-positions to facilitate intersystem crossing as usual and the introduction of triethylene glycol subunits to improve <span class="TC"><a class="simple" title="Chemspider Compound link for:water" target="_blank" href="http://www.chemspider.com/Chemical-Structure.937.html">water</a></span> solubility, which is a well precedented phenomenon to enhance cell permeability and tumor targeting properties in PSs<a title="Select to navigate to reference" href="#cit118"><sup><span class="sup_ref">118–120</span></sup></a>. PS <strong>38</strong> absorbs maximally at 660 nm with a high extinction coefficient of 102<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000 M<small><sup>−1</sup></small> cm<small><sup>−1</sup></small>, with no sign of aggregation in aqueous <span class="CH"><a class="simple" title="ChEBI Ontology link for: buffer" href="javascript:popupOBO('CHEBI:35225','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=35225')">buffer</a></span> medium. The phototoxicity with LED irradiation (625 nm at 2.5 mW cm<small><sup>−2</sup></small>, 4 h → 36 J cm<small><sup>−2</sup></small>) showed an EC<small><sub>50</sub></small> of less than 200 nM. PS <strong>41</strong> also showed a very low IC<small><sub>50</sub></small> (7 nM) against HT29 cells following irradiation (&gt;610 nm, 40 mW cm<small><sup>−2</sup></small>, 20 min → 48 J cm<small><sup>−2</sup></small>), with low aggregation in media.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig8"><img alt="Structures of dihalogenated symmetric distyryl BODIPY PSs." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f8.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 8 </b> <span id="fig8"><span class="graphic_title">Structures of dihalogenated symmetric <span class="TC"><a class="simple" title="Chemspider Compound link for:distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">distyryl</a></span> BODIPY PSs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Asymmetrical <span class="TC"><a class="simple" title="Chemspider Compound link for:distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">distyryl</a></span> BODIPY derivatives provide varying functionalization options to the applicability in PDT; they could offer the introduction of water-soluble moieties, such as polyethylene glycol units, as well as red-shifting through extended conjugation. Ng <span class="italic">et al.</span> prepared diiodinated asymmetric <span class="TC"><a class="simple" title="Chemspider Compound link for:distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">distyryl</a></span> analogues (<a title="Select to navigate to scheme" href="#imgsch4">Scheme 4</a>).<a title="Select to navigate to references" href="#cit121"><sup><span class="sup_ref">121</span></sup></a> The chemical modification to achieve unsymmetrical <span class="TC"><a class="simple" title="Chemspider Compound link for:distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">distyryl</a></span> BODIPY PSs is straightforward. Treatment of diiodo BODIPY with two different aryl aldehydes sequentially in 1 equivalence affords the variant condensed BODIPY. PS <strong>47</strong> showed high phototoxicity: IC<small><sub>50</sub></small> of 15 nM after irradiation (&gt;610 nm, 40 mW cm<small><sup>−2</sup></small>, 20 min → 48 J cm<small><sup>−2</sup></small>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch4"><img alt="Structures and synthesis of diiodinated asymmetric distyryl BODIPY PSs." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-s4.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 4 </b> <span id="sch4"><span class="graphic_title">Structures and synthesis of diiodinated asymmetric distyryl BODIPY PSs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Akkaya <span class="italic">et al.</span> proposed that SWNT (singlet wall <span class="CH"><a class="simple" title="ChEBI Ontology link for: carbon nanotube" href="javascript:popupOBO('CHEBI:50594','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=50594')">carbon nanotube</a></span>) has the potential to be used for delivery of PSs using non-covalent links.<a title="Select to navigate to references" href="#cit122"><sup><span class="sup_ref">122</span></sup></a> Pyrenyl-functionalized distyryl-BODIPY (<strong>48</strong>) was non-covalently added to SWNT. Singlet oxygen generation by indirect DPBF <span class="CH"><a class="simple" title="Molecular Process Ontology link for: oxidation" href="javascript:popupOBO('MOP:0000568','c2ra21404k')">oxidation</a></span> experiments showed 25% degradation of DPBF within 40 min with a result using a low concentration of conjugate <strong>48</strong>–SWNT (62.0 nM) as compared to just <strong>48</strong> (50 μM).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig9"><img alt="Pyrenyl-functionalized distyryl and heavy atom-substituted difuranylvinyl-BODIPYs." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f9.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 9 </b> <span id="fig9"><span class="graphic_title">Pyrenyl-functionalized <span class="TC"><a class="simple" title="Chemspider Compound link for:distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">distyryl</a></span> and heavy atom-substituted difuranylvinyl-BODIPYs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Prasad and co-workers prepared a new class of <span class="TC"><a class="simple" title="Chemspider Compound link for:distyryl" target="_blank" href="http://www.chemspider.com/Chemical-Structure.556946.html">distyryl</a></span> BODIPY PSs (<a title="Select to navigate to figure" href="#imgfig9">Fig. 9</a>), <span class="italic">e.g.</span>, 3,5-difuranylvinyl-BODIPYs (<strong>49</strong>–<strong>53</strong>).<a title="Select to navigate to references" href="#cit123"><sup><span class="sup_ref">123</span></sup></a> These BODIPYs can be synthesized by building a styryl-derived <span class="CH"><a class="simple" title="ChEBI Ontology link for: pyrrole" href="javascript:popupOBO('CHEBI:26455','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26455')">pyrrole</a></span> possessing a substituted <span class="CH"><a class="simple" title="ChEBI Ontology link for: phenyl" href="javascript:popupOBO('CHEBI:30396','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=30396')">phenyl</a></span> or heteroatomic subunits through the Wittig-type reaction. The approach generated PSs that absorb and emit in the far-red and NIR region (<span class="italic">λ</span><small><sub>abs</sub></small> = 628–713 nm and <span class="italic">λ</span><small><sub>em</sub></small> = 641–746 nm) with significant generation of <small><sup>1</sup></small>O<small><sub>2</sub></small> proved by the direct luminescence method with a phosphorescence spectra at 1270 nm from <small><sup>1</sup></small>O<small><sub>2</sub></small>.</p>
      
      
        
        <h3 id="sect736"><span class="b_heading">E3.2. Aza-BODIPY photosensitizers</span></h3>
        <span>The aza-BODIPY PSs prepared by O'Shea <span class="italic">et al.</span> are the most successful thus far in PDT among BODIPY-based PSs, owing to their excitation in the far-red region (∼650–688 nm), high generation of <small><sup>1</sup></small>O<small><sub>2</sub></small> (<span class="italic">Φ</span><small><sub>Δ</sub></small> = 0.74) and excellent optical and photophysical properties, such as a molar extinction coefficient of 75<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000 M<small><sup>−1</sup></small> cm<small><sup>−1</sup></small> and relatively good emission (<span class="italic">Φ</span><small><sub>f</sub></small> = 0.1), with a PP of 55<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>500 M<small><sup>−1</sup></small> cm<small><sup>−1</sup></small>.<a title="Select to navigate to references" href="#cit84"><sup><span class="sup_ref">84</span></sup></a> The BF<small><sub>2</sub></small> chelation of 3,5-diaryl-1<span class="italic">H</span>-pyrrol-2-yl-3,5-diarylpyrrol-2-ylidene <span class="CH"><a class="simple" title="ChEBI Ontology link for: amines" href="javascript:popupOBO('CHEBI:32952','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=32952')">amines</a></span> (tetraarylazadipyrromethenes) with subsequent incorporation of heavy atoms, such as bromine, to increase the triplet state population – a requisite for singlet oxygen generation – introduces a new class of photodynamic therapeutic agents.<a title="Select to navigate to references" href="#cit74"><sup><span class="sup_ref">74</span></sup></a></span>
        <p class="otherpara">Structural modifications of the aza-BODIPYs displayed varying degrees of singlet oxygen generation based on heavy atom (bromine) substitution without significant distortion to the planarity of the PSs (<a title="Select to navigate to figure" href="#imgfig10">Fig. 10</a>).<a title="Select to navigate to references" href="#cit83"><sup><span class="sup_ref">83</span></sup></a> The positioning and number of heavy atom substitution modulated the generation of <small><sup>1</sup></small>O<small><sub>2</sub></small> due to spin–orbit perturbation.<a title="Select to navigate to references" href="#cit124"><sup><span class="sup_ref">124</span></sup></a> To prove the possibility of spin–orbit perturbation, O'Shea and co-workers designed three aza-BODIPYs according to the following modules: i) relying on the inherent spin–orbit coupling of the aza-BODIPY without heavy atoms; ii) intramolecular external heavy-atom effect<a title="Select to navigate to reference" href="#cit125"><sup><span class="sup_ref">125–128</span></sup></a> in which bromine atoms are positioned on the <span class="CH"><a class="simple" title="ChEBI Ontology link for: aryl" href="javascript:popupOBO('CHEBI:33338','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33338')">aryl</a></span> rings and not on the aza-BODIPY core, giving rise to moderate <small><sup>1</sup></small>O<small><sub>2</sub></small> generation and iii) internal heavy atom effect<a title="Select to navigate to reference" href="#cit129"><sup><span class="sup_ref">129–131</span></sup></a> in which there is direct substitution of bromine atoms on the aza-BODIPY, yielding the <small><sup>1</sup></small>O<small><sub>2</sub></small> efficiently.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig10"><img alt="Singlet oxygen modulation by bromine positioning on the sensitizer core." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f10.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 10 </b> <span id="fig10"><span class="graphic_title">Singlet oxygen modulation by bromine positioning on the sensitizer core.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Phototoxicity against HeLa and MRC5-SV40 (transformed fibroblast) cell lines validated <small><sup>1</sup></small>O<small><sub>2</sub></small> generation <span class="italic">in vitro</span>; the most attractive module being the bromine substituted directly on the sensitizer to produce an internal heavy atom effect. The potential PDT-drugs were formulated using cremophor and displayed perinuclear localization. Irradiation of the plates was achieved using a long-wavelength light source 600–750 nm at a light dose of 8 or 16 J cm<small><sup>−2</sup></small> with the most effective (<strong>58</strong>, ADPM06, <a title="Select to navigate to figure" href="#imgfig11">Fig. 11</a>) showing an EC<small><sub>50</sub></small> of 63 nM and 37 nM at 8 J cm<small><sup>−2</sup></small> with no determinable dark toxicity in HeLa and MRC5-SV40 cell lines, respectively.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig11"><img alt="Structures of ADPM01 and ADPM06." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f11.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 11 </b> <span id="fig11"><span class="graphic_title">Structures of ADPM01 and ADPM06.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Further development of the aza-BODIPYs as effective anti-cancer therapeutics required comprehensive studies on ADPM06.<a title="Select to navigate to references" href="#cit132"><sup><span class="sup_ref">132</span></sup></a> The lead compound displayed localization in the cytoplasmic compartment with a large accumulation in the endoplasmic reticulum with minor localization to the mitochondria. ADPM06 induced apoptosis as a mechanism for cell death. Interestingly, under hypoxic conditions (1% oxygen) ADPM06 shows significant phototoxicity at 16 J cm<small><sup>−2</sup></small>, with EC<small><sub>50</sub></small> units of 1.5 and 1.6 μM for HeLa and MRC5 cell lines, respectively.</p>
        <p class="otherpara">The <span class="italic">in vivo</span> efficacy and mechanism of action of ADPM06 corroborated the anticancer therapeutic capacity of the BF<small><sub>2</sub></small> chelated aza-BODIPY.<a title="Select to navigate to references" href="#cit76"><sup><span class="sup_ref">76</span></sup></a> In the tolerance study using <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: LLC" href="javascript:popupOBO('CMO:0002317','c2ra21404k')">LLC</a></span>/1 tumour-bearing mice, ADPM06 showed early signs of tumor response. A critical look at the toxicity profiles revealed mass necrosis within 72–96 h at 150 J cm<small><sup>−2</sup></small>. Oedema and inflammation was observed by 1–2 days post-PDT treatment, with the oedema healing in a few days without tissue damage to the surrounding normal tissue. However, tumors took approximately 20–30 days to heal. Studies on xenograft models were carried out using MDA-MB-231-GFP cells inoculated subcutaneously into nude mice. Tumor sizes of 7–9 mm diameter were raised within 7–10 days for PDT treatment. Ablation of tumor was achieved with <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span>-light doses of 2 mg kg<small><sup>−1</sup></small> ADPM06 + 100–200 J cm<small><sup>−2</sup></small> (<a title="Select to navigate to figure" href="#imgfig12">Fig. 12a</a>). The highest cure rate of 71% was achieved at a <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span>-light dose of 2 mg kg<small><sup>−1</sup></small> ADPM06 + 150 J cm<small><sup>−2</sup></small> light.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig12"><img alt="(a) In vivo response to ADPM06-mediated PDT against MDA-MB-231-GFP xenograft model: PDT group (2 mg kg−1 ADPM06 IV + 150 J cm−2 light (n = 7)), light-alone group (150 J cm−2 (n = 8)), drug-alone group (2 mg kg−1 ADPM06 i. v. (n = 14)) and vehicle control (n = 9). (b) In vivo fluorescence images of ADPM06, as measured by optical imaging: Balb/C nude mice bearing subcutaneous MDA-MB-231-luc tumours before and after i. v. injection of ADPM06 (2 mg kg−1). Adopted with permission from ref. 71. Copyright 2009 Nature Publishing Group." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f12.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 12 </b> <span id="fig12"><span class="graphic_title">(a) <span class="italic">In vivo</span> response to ADPM06-mediated PDT against MDA-MB-231-GFP xenograft model: PDT group (2 mg kg<small><sup>−1</sup></small> ADPM06 IV + 150 J cm<small><sup>−2</sup></small> light (<span class="italic">n</span> = 7)), light-alone group (150 J cm<small><sup>−2</sup></small> (<span class="italic">n</span> = 8)), <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span>-alone group (2 mg kg<small><sup>−1</sup></small> ADPM06 i. v. (<span class="italic">n</span> = 14)) and vehicle control (<span class="italic">n</span> = 9). (b) <span class="italic">In vivo</span> fluorescence images of ADPM06, as measured by optical imaging: Balb/C nude mice bearing subcutaneous MDA-MB-231-luc tumours before and after i. v. injection of ADPM06 (2 mg kg<small><sup>−1</sup></small>). Adopted with permission from <a title="Select to navigate to references" href="#cit71">ref. 71</a>. Copyright 2009 Nature Publishing Group.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">One notable point with ADPM06 is that optical imaging could be used to establish <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span> biodistribution and clearance by <span class="italic">ex vivo</span> <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: fluorescence imaging" href="javascript:popupOBO('CMO:0000087','c2ra21404k')">fluorescence imaging</a></span> from excised organs (<a title="Select to navigate to figure" href="#imgfig12">Fig. 12b</a>), which has been difficult with <span class="CH"><a class="simple" title="ChEBI Ontology link for: porphyrin" href="javascript:popupOBO('CHEBI:26214','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26214')">porphyrin</a></span>-based PSs due to low fluorescence yield. It has been believed that one <span class="CH"><a class="simple" title="ChEBI Ontology link for: chromophore" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">chromophore</a></span> cannot be suitable for both singlet oxygen generation and fluorescence emission because these processes are competing. In other words, one <span class="CH"><a class="simple" title="ChEBI Ontology link for: chromophore" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">chromophore</a></span> cannot have both high singlet oxygen quantum yield and fluorescence quantum yield, which is true. However, it is possible to make azaBODIPYs with sufficient fluorescence brightness and high phototoxic power by balancing fluorescence and singlet oxygen quantum yields. For example, ADPM06 has achieved the correct balance to achieve both <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: fluorescence imaging" href="javascript:popupOBO('CMO:0000087','c2ra21404k')">fluorescence imaging</a></span> and high phototoxicity with a fluorescence quantum yield of 0.1 and a singlet oxygen quantum yield of 0.74.<a title="Select to navigate to reference" href="#cit62"><sup><span class="sup_ref">62,67,84</span></sup></a></p>
        <p class="otherpara">Anti-vascular PDT is effective since blood oxygen concentrations are high at vascular sites with high <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> levels in blood shortly post-injection. In addition, the accessibility of vascular endothelial cells to <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> molecules in blood is facile and direct. These benefits promote rapid vascular occlusion, discharging the PS molecules into the tumor region for efficient PDT.<a title="Select to navigate to reference" href="#cit133"><sup><span class="sup_ref">133,134</span></sup></a> The vascular targeting effect of ADPM06 was demonstrated by MRI and <span class="CH"><a class="simple" title="ChEBI Ontology link for: positron" href="javascript:popupOBO('CHEBI:30225','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=30225')">positron</a></span> emission tomography <span class="italic">in vivo</span> using a short <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span>-light interval. After <small><sup>18</sup></small>FDG-PET evidence showing transient metabolic status, i. v. injection of <span class="TC"><a class="simple" title="Chemspider Compound link for:Gd-DTPA" target="_blank" href="http://www.chemspider.com/Chemical-Structure.50087.html">Gd-DTPA</a></span> contrast agent (0.6 ml min<small><sup>−1</sup></small>) and MRI scans ∼3, 24 and 48 h post-treatment display a reduced vascular perfusion (<a title="Select to navigate to figure" href="#imgfig13">Fig. 13</a>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig13"><img alt="MRI approach to assessing vascular-targeting effect in vivo. The MRI of control 13762 MAT B III rat tumour (white circle) and PDT-treated tumour (0.8 mg kg−1 ADPM06 150 J cm−2 light) (dashed white circle) at 3, 24 and 48 h post-treatment with a Gd-DTPA injection, illustrating the change in tumour perfusion. Adopted with permission from ref. 71. Copyright 2009 Nature Publishing Group." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f13.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 13 </b> <span id="fig13"><span class="graphic_title">MRI approach to assessing vascular-targeting effect <span class="italic">in vivo</span>. The MRI of control 13762 MAT B III rat tumour (white circle) and PDT-treated tumour (0.8 mg kg<small><sup>−1</sup></small> ADPM06 150 J cm<small><sup>−2</sup></small> light) (dashed white circle) at 3, 24 and 48 h post-treatment with a Gd-DTPA injection, illustrating the change in tumour perfusion. Adopted with permission from <a title="Select to navigate to references" href="#cit71">ref. 71</a>. Copyright 2009 Nature Publishing Group.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">ADPM06-mediated PDT at short <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span>-light intervals imparts complete response rates in a variety of cancer models. An apoptosis response initiated by ROS beginning in the ER post-PDT with concurrent caspase <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: activation" href="javascript:popupOBO('CMO:0002196','c2ra21404k')">activation</a></span> <span class="italic">in vitro</span> can also be observed.<a title="Select to navigate to references" href="#cit135"><sup><span class="sup_ref">135</span></sup></a></p>
        <div>
          
          <span id="sect846"/><span class="c_heading_indent">E3.2.1. Aza-BODIPY in antimicrobial PDT. </span>
          <span>PDT presents a worthy alternative strategy to the treatment of resistant bacterial strains.<a title="Select to navigate to references" href="#cit136"><sup><span class="sup_ref">136</span></sup></a> In using PDT, a broad spectrum of pathogens, as well as resistant bacterial and fungal strains can be treated locally, which offers an advantage over <span class="CH"><a class="simple" title="ChEBI Ontology link for: antibacterial agents" href="javascript:popupOBO('CHEBI:33282','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33282')">antibacterial agents</a></span>, which may suffer the threat of potential resistance. The design of PSs for specific microbial infection could be fashioned in a way to enhance selectivity for microbial cell uptake. Prior works showed that neutral and anionic PSs have good uptake and impose significant <span class="CH"><a class="simple" title="ChEBI Ontology link for: antibiotic" href="javascript:popupOBO('CHEBI:22582','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=22582')">antibiotic</a></span> activity in gram-positive species and the use of membrane disrupting agents, such as <span class="TC"><a class="simple" title="Chemspider Compound link for:ethylenediaminetetraacetic acid" target="_blank" href="http://www.chemspider.com/Chemical-Structure.5826.html">ethylenediaminetetraacetic acid</a></span> or <span class="CH"><a class="simple" title="ChEBI Ontology link for: polymyxin" href="javascript:popupOBO('CHEBI:59062','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=59062')">polymyxin</a></span> B, may facilitate the photoinactivation of gram-negative species.<a title="Select to navigate to reference" href="#cit137"><sup><span class="sup_ref">137–139</span></sup></a> Recent research advances have proposed PSs with cationic moieties as having the ability to treat certain clinical indications such as wound disinfection, periodontal disease and blood sterilization, without the use of cell membrane disrupting agents.<a title="Select to navigate to references" href="#cit136"><sup><span class="sup_ref">136</span></sup></a> Hamblin <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit140"><sup><span class="sup_ref">140</span></sup></a> used poly-<span class="small_caps">L</span>-lysine-<span class="TC"><a class="simple" title="Chemspider Compound link for:chlorin" target="_blank" href="http://www.chemspider.com/Chemical-Structure.58616.html">chlorin</a></span> e6 conjugates (<strong>59a</strong>) to photoinactivate <span class="italic">Escherichia coli</span> and <span class="italic">in vivo</span> against <span class="italic">Pseudomonas aeroginosa</span> infected wounds with corresponding analogues bearing polyethyleneimine (<strong>59b</strong>) showing antimicrobial photoinactivation similar to the former, as well as the photoinactivation of methicillin-resistant <span class="italic">Staphylococcus aureus</span> in a mouse model to treat skin abrasion wounds (<a title="Select to navigate to figure" href="#imgfig14">Fig. 14</a>).<a title="Select to navigate to references" href="#cit141"><sup><span class="sup_ref">141</span></sup></a></span>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig14"><img alt="Antibacterial PDT agents." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f14.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 14 </b> <span id="fig14"><span class="graphic_title">Antibacterial PDT agents.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">In recent developments, Reddy <span class="italic">et al.</span> used a <span class="CH"><a class="simple" title="ChEBI Ontology link for: porphyrin" href="javascript:popupOBO('CHEBI:26214','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26214')">porphyrin</a></span>–apidaecin conjugate as a new broad <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: spectrum" href="javascript:popupOBO('CMO:0000800','c2ra21404k')">spectrum</a></span> <span class="CH"><a class="simple" title="ChEBI Ontology link for: antibacterial agent" href="javascript:popupOBO('CHEBI:33282','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=33282')">antibacterial agent</a></span>, underscoring the use of cationic moieties in antibacterial PDT.<a title="Select to navigate to references" href="#cit142"><sup><span class="sup_ref">142</span></sup></a> <span class="CH"><a class="simple" title="ChEBI Ontology link for: Porphyrins" href="javascript:popupOBO('CHEBI:26214','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=26214')">Porphyrins</a></span> substituted at the <span class="italic">meso</span> (<strong>60</strong>) positions with <span class="CH"><a class="simple" title="ChEBI Ontology link for: ammonium salts" href="javascript:popupOBO('CHEBI:47704','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=47704')">ammonium salts</a></span> perform photoinactivation of gram-positive bacteria to a large extent with reduced toxicity on eukaryotic cells.<a title="Select to navigate to references" href="#cit143"><sup><span class="sup_ref">143</span></sup></a> To further <span class="TC"><a class="simple" title="Chemspider Compound link for:affirm" target="_blank" href="http://www.chemspider.com/Chemical-Structure.8095964.html">affirm</a></span> the efficacy of antimicrobial PDT, the use of PSs in the phenthiazinium class, such as <span class="TC"><a class="simple" title="Chemspider Compound link for:methylene blue" target="_blank" href="http://www.chemspider.com/Chemical-Structure.5874.html">methylene blue</a></span> (<strong>61a</strong>) and <span class="TC"><a class="simple" title="Chemspider Compound link for:toluidine" target="_blank" href="http://www.chemspider.com/Chemical-Structure.13854136.html">toluidine</a></span> blue (<strong>61b</strong>), exhibit potency against blood pathogens and, in the case of <span class="TC"><a class="simple" title="Chemspider Compound link for:methylene blue" target="_blank" href="http://www.chemspider.com/Chemical-Structure.5874.html">methylene blue</a></span>, decontaminate freshly frozen blood plasma.<a title="Select to navigate to reference" href="#cit144"><sup><span class="sup_ref">144,145</span></sup></a> Like many PSs where the heavy atom effect contributes largely to ISC and attendant singlet oxygen generation. <strong>62</strong> containing selenium displays a far significant photoinactivation to a wide range of pathogens.<a title="Select to navigate to references" href="#cit146"><sup><span class="sup_ref">146</span></sup></a></p>
          <p class="otherpara">To obtain a single agent for antimicrobial PDT with a more straightforward synthesis amenable to structural modification with excellent photophysical properties, the aza-BODIPY was exploited. Drawing insights from ADPM06,<a title="Select to navigate to references" href="#cit83"><sup><span class="sup_ref">83</span></sup></a> O'Shea <span class="italic">et al.</span> synthesized a PS bearing two cationic <span class="CH"><a class="simple" title="ChEBI Ontology link for: ammonium salts" href="javascript:popupOBO('CHEBI:47704','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=47704')">ammonium salts</a></span>, <strong>63</strong> (<a title="Select to navigate to figure" href="#imgfig15">Fig. 15</a>).<a title="Select to navigate to references" href="#cit147"><sup><span class="sup_ref">147</span></sup></a></p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig15"><img alt="Aza-BODIPY antibacterial PS." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f15.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 15 </b> <span id="fig15"><span class="graphic_title">Aza-BODIPY antibacterial <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">The synthesis begins with the already reported bis-amine azadipyrromethene that can be accessed in three steps from <span class="TC"><a class="simple" title="Chemspider Compound link for:4-diethylaminomethyl benzaldehyde" target="_blank" href="http://www.chemspider.com/Chemical-Structure.23360889.html">4-diethylaminomethyl benzaldehyde</a></span> and <span class="TC"><a class="simple" title="Chemspider Compound link for:4-methoxyacetophenone" target="_blank" href="http://www.chemspider.com/Chemical-Structure.13835344.html">4-methoxyacetophenone</a></span>. <span class="CH"><a class="simple" title="Molecular Process Ontology link for: Bromination" href="javascript:popupOBO('MOP:0000551','c2ra21404k')">Bromination</a></span> at room temperature and BF<small><sub>2</sub></small> chelation with <span class="TC"><a class="simple" title="Chemspider Compound link for:boron trifluoride" target="_blank" href="http://www.chemspider.com/Chemical-Structure.6116.html">boron trifluoride</a></span> and <span class="TC"><a class="simple" title="Chemspider Compound link for:diisopropylethylamine" target="_blank" href="http://www.chemspider.com/Chemical-Structure.73565.html">diisopropylethylamine</a></span> were followed by <span class="CH"><a class="simple" title="ChEBI Ontology link for: alkyl" href="javascript:popupOBO('CHEBI:22323','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=22323')">alkyl</a></span> substitution with <span class="TC"><a class="simple" title="Chemspider Compound link for:iodomethane" target="_blank" href="http://www.chemspider.com/Chemical-Structure.6088.html">iodomethane</a></span>, which affords the target compound.</p>
          <p class="otherpara">The photodynamic applicability of <strong>63</strong> in inactivating microbes is broad. Experimentally, the PSs with the bis-ammonium salts facilitates rapid uptake, ∼10 min in Gram-positive and negative bacterial strains and pathogenic yeasts which is due to the amphiphilic nature of the PS and the log P values close to zero (−0.25). Confocal images of <strong>63</strong> confirmed the broad-spectrum microbial uptake after a 10 min incubation period. A localization pattern observed in <span class="italic">E. coli</span> showed staining throughout the cell with an intense staining pattern on the outer periphery edge of the cell. Antibacterial phototoxicity using 1, 2 and 5 μg mL<small><sup>−1</sup></small> of <strong>63</strong> was significant. A notable <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span>-light dose of 5 μg mL<small><sup>−1</sup></small> and 16 J cm<small><sup>−2</sup></small> achieved a 6.8 and 3.4 log<small><sub>10</sub></small> <span class="CH"><a class="simple" title="Molecular Process Ontology link for: reduction" href="javascript:popupOBO('MOP:0000569','c2ra21404k')">reduction</a></span> of <span class="italic">S. aureus</span> and a methicillin-resistant <span class="italic">S. aureus</span> (MRSA) strain, respectively. Additionally, using 5 μg mL<small><sup>−1</sup></small> of <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> and 75 J cm<small><sup>−2</sup></small> a broad pathogenic inactivity resulted up to 3.6 and 5.7 log<small><sub>10</sub></small> for gram-negative bacterium <span class="italic">E. coli</span> and the pathogenic yeast <span class="italic">C. albicans</span>, respectively.</p>
        </div>
      
      
        
        <h3 id="sect929"><span class="b_heading">E4. Heavy atom-free BODIPY photosensitizers</span></h3>
        <span>Developing BODIPY photosensitizers without the incorporation of heavy atoms, such as iodine, bromine, selenium, sulphur and certain lanthanides, may offer reduced dark toxicity. The low triplet population of the BODIPY <span class="CH"><a class="simple" title="ChEBI Ontology link for: chromophore" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">chromophore</a></span> means a focus on the excited state properties may be the key to achieving high ISC without heavy atoms. The recent developments of heavy atom-free BODIPY PSs has focused on: 1) dimeric BODIPY at an orthogonal orientation, which imparts an unperturbed HOMO → LUMO due to the lack of orthogonal π-framework <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: mixing" href="javascript:popupOBO('CMO:0001685','c2ra21404k')">mixing</a></span> (a thorough discussion on theoretical insight is given in section H of this review);<a title="Select to navigate to references" href="#cit148"><sup><span class="sup_ref">148</span></sup></a> or 2) the use of spin convertors, such as C60, in dyads to sensitize photophysical processes, like singlet oxygen generation, by intramolecular energy transfer (EnT). The former employs the synthesis of <span class="italic">meso</span>-β linked BODIPY with visible absorption of 500–542 nm and <span class="italic">Φ</span><small><sub>Δ</sub></small> = 0.21–0.51.<a title="Select to navigate to reference" href="#cit148"><sup><span class="sup_ref">148,149</span></sup></a> The first approach resulted in a potent photosensitizer with <span class="italic">in vitro</span> phototoxicity at nanomolar concentrations, but it looks far from practical for <span class="italic">in vivo</span> use in PDT due to the short wavelength (∼520 nm). The latter strategy uses the light harvesting styryl-BODIPY or azaBODIPY<a title="Select to navigate to references" href="#cit150"><sup><span class="sup_ref">150</span></sup></a> in conjugation with C60 units. Their photophysical properties are attractive, with absorption at 629–657 nm and a high <span class="italic">Φ</span><small><sub>Δ</sub></small> of 0.85 (for styryl BODIPY). The translation of these dyads into biological efficacy would be interesting.<a title="Select to navigate to references" href="#cit151"><sup><span class="sup_ref">151</span></sup></a></span>
      
    
    
      
      <h2 id="sect946"><span class="a_heading">F. Activatable BODIPY-based photosensitizers</span></h2>
      <span>Activatable <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> is a unique approach to achieve additional selectivity in PDT to diseased tissue over normal tissue.<a title="Select to navigate to references" href="#cit58"><sup><span class="sup_ref">58</span></sup></a> Activatable BODIPY-based fluorophores have been successfully demonstrated in imaging to distinguish healthy cells from diseased ones.<a title="Select to navigate to reference" href="#cit152"><sup><span class="sup_ref">152–154</span></sup></a> Since the singlet oxygen generation shares some dynamic processes with fluorescence emission, the activation mechanisms for BODIPY-based PSs may be adopted from those for BODIPY fluorophores. There have been a number of <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: activation" href="javascript:popupOBO('CMO:0002196','c2ra21404k')">activation</a></span> modalities for BODIPY-PSs that have been studied over the years, such as pH, hydrophobicity, nucleic acid activated and ions, most of which control photo-induced <span class="CH"><a class="simple" title="Molecular Process Ontology link for: electron transfer" href="javascript:popupOBO('MOP:0000615','c2ra21404k')">electron transfer</a></span> (PeT, <a title="Select to navigate to figure" href="#imgfig16">Fig. 16</a>).</span>
      <p class="otherpara">PeT is a well-studied on/off switch mechanism to control fluorescence.<a title="Select to navigate to references" href="#cit155"><sup><span class="sup_ref">155</span></sup></a> The selective photoinactivation of specific <span class="CH"><a class="simple" title="ChEBI Ontology link for: proteins" href="javascript:popupOBO('CHEBI:36080','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=36080')">proteins</a></span>, also called CALI (<span class="CH"><a class="simple" title="ChEBI Ontology link for: chromophore" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">chromophore</a></span> assisted light inactivation), using the PeT approach in combination with environment <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: activation" href="javascript:popupOBO('CMO:0002196','c2ra21404k')">activation</a></span> strategies was demonstrated (<a title="Select to navigate to figure" href="#imgfig17">Fig. 17b</a>).<a title="Select to navigate to references" href="#cit156"><sup><span class="sup_ref">156</span></sup></a> The development of PSs bearing varying <span class="CH"><a class="simple" title="ChEBI Ontology link for: electron donors" href="javascript:popupOBO('CHEBI:15022','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=15022')">electron donors</a></span> as a tunable PeT quencher with an inositol 1,4,5-trisphosphate receptor (IP<small><sub>3</sub></small>R) <span class="CH"><a class="simple" title="ChEBI Ontology link for: ligand" href="javascript:popupOBO('CHEBI:52214','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=52214')">ligand</a></span> presents effective on/off switching of <small><sup>1</sup></small>O<small><sub>2</sub></small> generation. The transfer of electrons by the donor moiety quenches the <small><sup>1</sup></small>O<small><sub>2</sub></small> generation (switch off) of the unbound molecule. However, upon specific binding to the hydrophobic pocket of the inositol 1,4,5-trisphosphate receptor, the switch is on, ready to generate <small><sup>1</sup></small>O<small><sub>2</sub></small> upon irradiation. This PeT-hydrophobic environment strategy demonstrated a unique activatable <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> approach based on the BODIPY <span class="CH"><a class="simple" title="ChEBI Ontology link for: chromophore" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">chromophore</a></span> for the selective inactivation of <span class="CH"><a class="simple" title="ChEBI Ontology link for: protein" href="javascript:popupOBO('CHEBI:36080','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=36080')">protein</a></span> function.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig16"><img alt="The general mechanism of PeT. PS: photosensitizer, A: auxiliary group, A′; modified auxiliary group." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f16.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 16 </b> <span id="fig16"><span class="graphic_title">The general mechanism of PeT. <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span>: photosensitizer, A: auxiliary group, A′; modified auxiliary group.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig17"><img alt="(a) The structure of 64 (ESPer d-IP3) and (b) a schematic representation of protein photoinactivation using ESPers. In the cytosolic polar environment, ESPers are in the off state of photosensitization (indicated by light blue) and do not generate 1O2. In the hydrophobic environment of the target, ESPers are in the on state of photosensitization (indicated by red) and generate 1O2, inducing inactivation of the nearby protein of interest. Adopted with permission from ref. 142. Copyright 2008 National Academy of Sciences, USA." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f17.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 17 </b> <span id="fig17"><span class="graphic_title">(a) The structure of <strong>64</strong> (ESPer d-IP<small><sub>3</sub></small>) and (b) a schematic representation of <span class="CH"><a class="simple" title="ChEBI Ontology link for: protein" href="javascript:popupOBO('CHEBI:36080','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=36080')">protein</a></span> photoinactivation using ESPers. In the cytosolic polar environment, ESPers are in the off state of photosensitization (indicated by light blue) and do not generate <small><sup>1</sup></small>O<small><sub>2</sub></small>. In the hydrophobic environment of the target, ESPers are in the on state of photosensitization (indicated by red) and generate <small><sup>1</sup></small>O<small><sub>2</sub></small>, inducing inactivation of the nearby <span class="CH"><a class="simple" title="ChEBI Ontology link for: protein" href="javascript:popupOBO('CHEBI:36080','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=36080')">protein</a></span> of interest. Adopted with permission from <a title="Select to navigate to references" href="#cit142">ref. 142</a>. Copyright 2008 National Academy of Sciences, USA.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">PeT was also utilized as a selective mechanism for ADPM PSs bearing <span class="CH"><a class="simple" title="ChEBI Ontology link for: amine" href="javascript:popupOBO('CHEBI:32952','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=32952')">amine</a></span> receptors activated by pH. In this approach, a <span class="CH"><a class="simple" title="ChEBI Ontology link for: proton" href="javascript:popupOBO('CHEBI:24636','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=24636')">proton</a></span> source acted as an activator, so called supramolecular photonic therapeutic agents (SPTA).<a title="Select to navigate to references" href="#cit157"><sup><span class="sup_ref">157</span></sup></a> The approach took advantage of the lower pH (6.5–6.8) associated with the interstitial fluid surrounding the tumor mass over normal tissue. Different <span class="CH"><a class="simple" title="ChEBI Ontology link for: amine" href="javascript:popupOBO('CHEBI:32952','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=32952')">amine</a></span> receptors can modulate the degree of <small><sup>1</sup></small>O<small><sub>2</sub></small> generated, thereby impacting the phototoxicity. The on/off switch by the PeT–pH response strategy utilized the rationally chosen <span class="CH"><a class="simple" title="ChEBI Ontology link for: amine" href="javascript:popupOBO('CHEBI:32952','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=32952')">amine</a></span> receptors to achieve significant cytotoxicity of EC<small><sub>50</sub></small> values of up to 5.8 nM at 16 J cm<small><sup>−2</sup></small> light irradiation with <strong>65</strong>.</p>
      <p class="otherpara">Molecular logic gates were proposed for use in synthetic RNA-based logic devices (fluorescent <span class="CH"><a class="simple" title="ChEBI Ontology link for: proteins" href="javascript:popupOBO('CHEBI:36080','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=36080')">proteins</a></span>),<a title="Select to navigate to references" href="#cit158"><sup><span class="sup_ref">158</span></sup></a> small object coding<a title="Select to navigate to references" href="#cit159"><sup><span class="sup_ref">159</span></sup></a> and pro-<span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span> <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: activation" href="javascript:popupOBO('CMO:0002196','c2ra21404k')">activation</a></span>,<a title="Select to navigate to references" href="#cit160"><sup><span class="sup_ref">160</span></sup></a> to mention a few examples. Designs involving a receptor (molecule) with two input channels mimic the molecular AND logic gate approach to achieve selectivity.<a title="Select to navigate to references" href="#cit161"><sup><span class="sup_ref">161</span></sup></a> The AND gate is designed to follow a digital logic gate system, in which a logical conjunction of all high inputs to the AND gate yields a high output and a low output is obtained if neither or only one input is high.<a title="Select to navigate to reference" href="#cit161"><sup><span class="sup_ref">161,162</span></sup></a> <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span> present a wide range of synthetic flexibility to obtain a “chemical” AND logic gate. Singlet oxygen acts as the output with chemical inputs drawn from the microenvironment of the diseased tissue, such as cancers. Large acidic vesicles other than endosomes and lysosomes contained in metastatic cancer cells may contribute to a the low pH of &lt;4.<a title="Select to navigate to references" href="#cit163"><sup><span class="sup_ref">163</span></sup></a> In addition, intracellular sodium ion concentration is ∼3 times higher than in normal tissues.<a title="Select to navigate to references" href="#cit164"><sup><span class="sup_ref">164</span></sup></a> The variants observed in the cancer tissue environment make Na<small><sup>+</sup></small> and H<small><sup>+</sup></small> unique chemical inputs for the BODIPY AND logic gate.<a title="Select to navigate to references" href="#cit165"><sup><span class="sup_ref">165</span></sup></a> The smart synthetic design possesses a <span class="CH"><a class="simple" title="ChEBI Ontology link for: crown" href="javascript:popupOBO('CHEBI:37409','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37409')">crown</a></span>-<span class="CH"><a class="simple" title="ChEBI Ontology link for: ether" href="javascript:popupOBO('CHEBI:25698','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=25698')">ether</a></span>-based PeT modulator sensitive to only Na<small><sup>+</sup></small> and dimethylaminostyryl or pyridilethynyl fragments sensitive to acidic treatment (H<small><sup>+</sup></small>) (<a title="Select to navigate to figure" href="#imgfig18">Fig. 18</a>). Therefore, following the principle of molecular AND logic gates, high concentrations of both Na<small><sup>+</sup></small> and H<small><sup>+</sup></small> ions turns on the output, producing singlet oxygen in significantly high amounts relative to neither or only one high Na<small><sup>+</sup></small> or H<small><sup>+</sup></small>. Although this application may not have been tested <span class="italic">in vitro</span>, it offers a potentially selective approach to the treatment of malignant diseases by molecular-based logic gates.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig18"><img alt="Structures of aza-BODIPY PSs." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f18.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 18 </b> <span id="fig18"><span class="graphic_title">Structures of aza-BODIPY PSs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      
      <h2 id="sect1027"><span class="a_heading">G. Computational platforms of BODIPY-based photosensitizers</span></h2>
      <span>Computational calculations are not perfect yet, but are useful for various applications in the <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span> design process to save time and other resources. Theoretical calculations of BODIPY-based PSs have also been proven useful in the design of new PSs and analysing <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: experimental data" href="javascript:popupOBO('CMO:0000793','c2ra21404k')">experimental data</a></span>. In particular, quantum mechanical calculations were used to calculate geometry and electronic characteristics of molecules, such as geometry optimization, <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: electronic spectra" href="javascript:popupOBO('CMO:0000811','c2ra21404k')">electronic spectra</a></span>, energy levels and gaps, and electron density maps, which are important determinants for key photophysical properties of effective PSs.</span>
      <p class="otherpara">A detailed computational study on the tetraazadipyrromethene class of <span class="CH"><a class="simple" title="ChEBI Ontology link for: dyes" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dyes</a></span> developed by Russo <span class="italic">et al.</span> revealed the geometric character, excited state behaviour (both absorption band and singlet–triplet energy gap) and <span class="CH"><a class="simple" title="ChEBI Ontology link for: solvent" href="javascript:popupOBO('CHEBI:46787','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=46787')">solvent</a></span> effect providing useful insights into these novel classes of PSs.<a title="Select to navigate to references" href="#cit166"><sup><span class="sup_ref">166</span></sup></a> The computational model used was the Gaussian 03 package employing DFT level and PBE0 hybrid functional with 25% of exact exchange in association with split valence basis sets supported with polarization functions (SVP). The 6-31+G* and the PBE0 functional was appropriate in the prediction of the absorption bands by TD-DFT calculations, while the polarization continuum model (<span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PCM" href="javascript:popupOBO('CMO:0000110','c2ra21404k')">PCM</a></span>) model was suitable in assessing the <span class="CH"><a class="simple" title="ChEBI Ontology link for: solvent" href="javascript:popupOBO('CHEBI:46787','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=46787')">solvent</a></span> effects.</p>
      <p class="otherpara">The positioning of the four <span class="CH"><a class="simple" title="ChEBI Ontology link for: phenyl" href="javascript:popupOBO('CHEBI:30396','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=30396')">phenyl</a></span> rings in relation to the core of the aza-BODIPY structure is defined by the four dihedral angles (<span class="italic">Ψ</span><small><sub>1</sub></small>, <span class="italic">Ψ</span><small><sub>2</sub></small>, <span class="italic">Ψ</span><small><sub>3</sub></small>, <span class="italic">Ψ</span><small><sub>4</sub></small>) that describe the conformation of the ground state geometric structures (<a title="Select to navigate to figure" href="#imgfig20">Fig. 20</a>). Thus, the most stable conformers were calculated relative to the dihedral angles. The calculated bond lengths and balance angles of the optimized structures were in agreement with <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: experimental data" href="javascript:popupOBO('CMO:0000793','c2ra21404k')">experimental data</a></span>. The four <span class="CH"><a class="simple" title="ChEBI Ontology link for: phenyl" href="javascript:popupOBO('CHEBI:30396','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=30396')">phenyl</a></span> rings were positioned out of plane at the energy minimized conformations. Theoretical predictions of the absorption band were also compared with experimentally observed <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: UV-visible" href="javascript:popupOBO('CMO:0000292','c2ra21404k')">UV-visible</a></span> <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: spectra" href="javascript:popupOBO('CMO:0000800','c2ra21404k')">spectra</a></span>, also showing impacts of the substituents on the absorption maxima. A more interesting and useful prediction was the singlet–triplet energy gap, since a fundamental requisite for PSs to obtain PDT efficacy is displayed by its singlet–triplet energy gap (≥0.98 eV). However, some differences seen in the computational assessment warrants a caution in the interpretation of energy gap results for predicting singlet oxygen generation capability.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig19"><img alt="BODIPY-based molecular AND logic gate." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f19.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 19 </b> <span id="fig19"><span class="graphic_title">BODIPY-based molecular AND logic gate.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">You <span class="italic">et al.</span> in an effort to understand the theoretical framework of NIR <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span> (<strong>20</strong>–<strong>25</strong>, <a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) that generate singlet oxygen used the density functional theory (DFT) and time-dependent density functional theory (TDDFT) in Gaussian 09 to gain an insight in to the geometric and excited state character of the synthesized compounds.<a title="Select to navigate to references" href="#cit87"><sup><span class="sup_ref">87</span></sup></a> Using the 6-311G* basis set for geometry optimization and the PBEPBE correlation functional <span class="italic">in vacuo</span>, the excited state calculation exhibited strong absorption bands in the NIR region, which compared appropriately with experimental <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: UV spectra" href="javascript:popupOBO('CMO:0001254','c2ra21404k')">UV spectra</a></span> data at Δ<span class="italic">E</span> = 0.06 eV (<a title="Select to navigate to figure" href="#imgfig21">Fig. 21</a>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig20"><img alt="The structure of BF2-chelated tetraarylazadipyrromethenes used in the study, with the atom, substituent and free-rotation torsion angle labelling." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f20.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 20 </b> <span id="fig20"><span class="graphic_title">The structure of BF<small><sub>2</sub></small>-chelated tetraarylazadipyrromethenes used in the study, with the atom, substituent and free-rotation torsion angle <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: labelling" href="javascript:popupOBO('CMO:0001675','c2ra21404k')">labelling</a></span>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Ortiz <span class="italic">et al.</span> used electrostatic potential maps and Mulliken charges of BODIPY to estimate sites for electrophilic <span class="CH"><a class="simple" title="RXNO Ontology link for: aromatic substitution" href="javascript:popupOBO('RXNO:0000020','c2ra21404k')">aromatic substitution</a></span> in the polyiodination of BODIPY.<a title="Select to navigate to references" href="#cit88"><sup><span class="sup_ref">88</span></sup></a> The calculated data were used to rationally justify the sites of <span class="CH"><a class="simple" title="Molecular Process Ontology link for: iodination" href="javascript:popupOBO('MOP:0000554','c2ra21404k')">iodination</a></span>, which were not only affected by an electronic factor, but also by a steric factor. They also observed that photophysical properties of polyiodinated BODIPYs depended on the sites of <span class="CH"><a class="simple" title="Molecular Process Ontology link for: iodination" href="javascript:popupOBO('MOP:0000554','c2ra21404k')">iodination</a></span>. <span class="CH"><a class="simple" title="Molecular Process Ontology link for: Iodination" href="javascript:popupOBO('MOP:0000554','c2ra21404k')">Iodination</a></span> at the 3 or 5-position improved the absorption and emission efficiencies more than the other positions.</p>
      <p class="otherpara">Recently, Akkaya and co-workers nicely proved a new concept for generating singlet oxygen from <span class="CH"><a class="simple" title="ChEBI Ontology link for: BODIPY dyes" href="javascript:popupOBO('CHEBI:51123','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=51123')">BODIPY dyes</a></span> without using heavy atom effects.<a title="Select to navigate to references" href="#cit148"><sup><span class="sup_ref">148</span></sup></a> The heavy atom-free BODIPY PSs have been further explored through styryl BODIPY-C60 dyads showing strong absorption of visible light at 657 nm and an extinction coefficient of 64<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>600 M<small><sup>−1</sup></small> cm<small><sup>−1</sup></small> with a delay of <span class="italic">Φ</span><small><sub>Δ</sub></small> = 0.85. The concept was supported by theoretical insights into excited states using the complete active space SCF (a variant of MCSCF) with large basis sets and different active spaces. They synthesized orthogonal BODIPY dimers as a non-halogenated BODIPY efficient <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span>, where the tuning of excited states properties by raising the structure and electronic compatibility of S<small><sub>1</sub></small> and T<small><sub>1</sub></small> states over S<small><sub>1</sub></small>–S<small><sub>0</sub></small> (fluorescence pathway) increased intersystem crossing without the use of heavy atoms. Singlet oxygen was directly detected using a near-IR sensitive <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: detector" href="javascript:popupOBO('CMO:0002244','c2ra21404k')">detector</a></span> and potent phototoxicity (EC<small><sub>50</sub></small> = 50 nM) was observed against K562 human erythroleukemia cells after irradiation (520 nm LED, 2.5 mW cm<small><sup>−2</sup></small>, 4 h). From more extensive theoretical and experimental studies, they found that DS-TR (doubly substituted tetraradical configuration) is a valuable descriptor for estimating the photosensitization potential of such orthogonal dimers.<a title="Select to navigate to references" href="#cit167"><sup><span class="sup_ref">167</span></sup></a> However, the orthogonal BODIPY dimers may not be good for pursuing longer wavelength absorbing PSs. The extension of the π-system of BODIPY in the dimers seemed to destabilize the DS-TR, but stabilize SS (<a title="Select to navigate to figure" href="#imgfig22">Fig. 22</a>). The dimers with π-extended conjugated BODIPY did not generate singlet oxygen. This is an excellent case of using computer-assisted excited <span class="CH"><a class="simple" title="Chemical Methods Ontology link for: PS" href="javascript:popupOBO('CMO:0002186','c2ra21404k')">PS</a></span> design and getting an insight into the excited states to understand behaviours of PSs.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig21"><img alt="The observed trend for calculated excitation energies and experimental absorption maxima in eV. Adopted with permission from ref. 81. Copyright 2011 American Chemical Society." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f21.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 21 </b> <span id="fig21"><span class="graphic_title">The observed trend for calculated excitation energies and experimental absorption maxima in eV. Adopted with permission from <a title="Select to navigate to references" href="#cit81">ref. 81</a>. Copyright 2011 American Chemical Society.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig22"><img alt="Relation of DS-TR and SS characters of S1 to pi-conjugation and tendency of ISC (DS-TR: doubly substituted tetraradical S1 state, SS: singly substituted HOMO → LUMO type open shell S1). Top: configuration of dimers, Bottom: monomeric structures of the dimers. Adopted with permission from ref. 152. Copyright 2012 American Chemical Society." src="/image/article/2012/RA/c2ra21404k/c2ra21404k-f22.gif"/></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 22 </b> <span id="fig22"><span class="graphic_title">Relation of DS-TR and SS characters of S<small><sub>1</sub></small> to pi-conjugation and tendency of ISC (DS-TR: doubly substituted tetraradical S<small><sub>1</sub></small> state, SS: singly substituted HOMO → LUMO type open shell S<small><sub>1</sub></small>). Top: configuration of dimers, Bottom: monomeric structures of the dimers. Adopted with permission from <a title="Select to navigate to references" href="#cit152">ref. 152</a>. Copyright 2012 American Chemical Society.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      
      <h2 id="sect1107"><span class="a_heading">H. Conclusion and future direction</span></h2>
      <span>Since the early publicaton by O'Shea <span class="italic">et al.</span> of aza-BODIPY PSs in 2002, the BODIPY class PSs have shown great promise in a very short period of time. ADPM06 is an excellent example that was demonstrated to be effective for <span class="italic">in vivo</span> models. It is unequivocal that BODIPY-based PSs have great potential as a new class of PSs, offering critical advantages, such as the excellent and tunable photophysical properties and flexible synthesis. Those make BODIPY a very attractive <span class="CH"><a class="simple" title="ChEBI Ontology link for: chromophore" href="javascript:popupOBO('CHEBI:23240','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23240')">chromophore</a></span> for an ideal PS. In addition, the recent explosion in knowledge about BODIPYs as fluorescence <span class="CH"><a class="simple" title="ChEBI Ontology link for: dyes" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dyes</a></span>, simple methods for converting from fluorescence <span class="CH"><a class="simple" title="ChEBI Ontology link for: dyes" href="javascript:popupOBO('CHEBI:37958','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=37958')">dyes</a></span> to PSs and relatively reliable theoretical tools could provide ideas for designing new BODIPY-based PSs. As demonstrated by the presented cases, BODIPY-based PSs can be used as an excellent platform for advanced PSs with 1) absorption and emission near 700 nm with high efficiency, 2) activatable photosensitization and 3) a dual functionality for theranostic PSs, balanced and effective singlet oxygen generation and fluorescence emission. Based on such promising results at very early <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span> discovery stages, BODIPY-based PSs should be proved effective at more advanced discovery stages, such as preclinical and eventually clinical studies.</span>
    
  
    <h2 id="sect1118"><span class="a_heading">Acknowledgements</span></h2>
      <span>We acknowledge the Oklahoma Center for the Advancement of Science and Technology (OCAST) for financial support and ChemAxon for free access to Instant JChem used in compiling the BODIPY database found in the ESI<a title="Select to navigate to footnote" href="#fn1">†</a>.</span>
    
    <span id="sect1121"><h2 id="sect1117"><span class="a_heading">References</span></h2></span><ol type="1">
      <li><span id="cit1">T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, <span class="italic">J. Natl. Cancer Inst.</span>, 1998, <span class="bold">90</span>, 889–905 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/jnci/90.12.889" title="DOI Link to resource 10.1093/jnci/90.12.889">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1cXktFOqsLY%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit2">M. A. MacCormack, <span class="italic">Semin. Cutaneous Med. Surg.</span>, 2008, <span class="bold">27</span>, 52–62 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.sder.2007.12.001" title="DOI Link to resource 10.1016/j.sder.2007.12.001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXmvFajtLg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit3">T. J. Dougherty, <span class="italic">J. Clin. Laser Med. Surg.</span>, 2002, <span class="bold">20</span>, 3–7 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Clin.%20Laser%20Med.%20Surg.%5BJour%5D%20AND%2020%5Bvolume%5D%20AND%203%5Bpage%5D%20and%202002%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit4">A. Juzeniene, Q. Peng and J. Moan, <span class="italic">Photochem. Photobiol. Sci.</span>, 2007, <span class="bold">6</span>, 1234–1245 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKrt7jN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit5">P. Babilas, S. Schreml, M. Landthaler and R. M. Szeimies, <span class="italic">Photodermatol., Photoimmunol. Photomed.</span>, 2010, <span class="bold">26</span>, 118–132 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1600-0781.2010.00507.x" title="DOI Link to resource 10.1111/j.1600-0781.2010.00507.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXoslyksr4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit6">S. Kossodo and G. M. LaMuraglia, <span class="italic">Am. J. Cardiovasc. Drugs</span>, 2001, <span class="bold">1</span>, 15–21 <a target="_blank" class="DOILink" href="https://doi.org/10.2165/00129784-200101010-00002" title="DOI Link to resource 10.2165/00129784-200101010-00002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD2c%252FivVarug%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit7">J. Garrier, L. Bezdetnaya, C. Barlier, S. Grafe, F. Guillemin and M. A. D'Hallewin, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2011, <span class="bold">8</span>, 321–327 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.pdpdt.2011.06.003" title="DOI Link to resource 10.1016/j.pdpdt.2011.06.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGjsbbJ" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit8">A. Loudet and K. Burgess, <span class="italic">Chem. Rev.</span>, 2007, <span class="bold">107</span>, 4891–4932 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr078381n" title="DOI Link to resource 10.1021/cr078381n">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXhtFeisbvF" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit9">N. Boens, V. Leen and W. Dehaen, <span class="italic">Chem. Soc. Rev.</span>, 2012, <span class="bold">41</span>, 1130–1172 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C1CS15132K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C1CS15132K">RSC</a>.</span></li>
      <li><span id="cit10">G. Ulrich, R. Ziessel and A. Harriman, <span class="italic">Angew. Chem., Int. Ed.</span>, 2008, <span class="bold">47</span>, 1184–1201 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200702070" title="DOI Link to resource 10.1002/anie.200702070">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXit1Gqs7w%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit11">K. Plaetzer, B. Krammer, J. Berlanda, F. Berr and T. Kiesslich, <span class="italic">Lasers Med. Sci.</span>, 2009, <span class="bold">24</span>, 259–268 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10103-008-0539-1" title="DOI Link to resource 10.1007/s10103-008-0539-1">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD1M7lvV2itw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit12">C. S. Foote, <span class="italic">Photochem. Photobiol.</span>, 1991, <span class="bold">54</span>, 659 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1751-1097.1991.tb02071.x" title="DOI Link to resource 10.1111/j.1751-1097.1991.tb02071.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3MXms1Kmsrw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit13">L. Brancaleon and H. Moseley, <span class="italic">Lasers Med. Sci.</span>, 2002, <span class="bold">17</span>, 173–186 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s101030200027" title="DOI Link to resource 10.1007/s101030200027">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD38visVKntw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit14">T. S. Mang, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2004, <span class="bold">1</span>, 43–48 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1572-1000(04)00012-2" title="DOI Link to resource 10.1016/S1572-1000(04)00012-2">CrossRef</a>.</span></li>
      <li><span id="cit15">K. R. Weishaupt, C. J. Gomer and T. J. Dougherty, <span class="italic">Cancer Res.</span>, 1976, <span class="bold">36</span>, 2326–2329 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE28XkslKisrw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit16">J. Moan and S. Sommer, <span class="italic">Cancer Res.</span>, 1985, <span class="bold">45</span>, 1608–1610 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL2MXhvVWlsbY%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit17">H. I. Pass, <span class="italic">J. Natl. Cancer Inst.</span>, 1993, <span class="bold">85</span>, 443–456 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/jnci/85.6.443" title="DOI Link to resource 10.1093/jnci/85.6.443">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaK3s7ovVSnuw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit18">B. W. Henderson and T. J. Dougherty, <span class="italic">Photochem. Photobiol.</span>, 1992, <span class="bold">55</span>, 145–157 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1751-1097.1992.tb04222.x" title="DOI Link to resource 10.1111/j.1751-1097.1992.tb04222.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK38XnvFCiuw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit19">M. C. DeRosa and R. J. Crutchley, <span class="italic">Coord. Chem. Rev.</span>, 2002, <span class="bold">233–234</span>, 351–371 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0010-8545(02)00034-6" title="DOI Link to resource 10.1016/S0010-8545(02)00034-6">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XosFOmsb8%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit20">R. Schmidt, <span class="italic">Photochem. Photobiol.</span>, 2006, <span class="bold">82</span>, 1161–1177 <a target="_blank" class="DOILink" href="https://doi.org/10.1562/2006-03-03-IR-833" title="DOI Link to resource 10.1562/2006-03-03-IR-833">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtFGhsLvK" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit21">
          M. Montalti and S. L. Murov, <span class="italic">Handbook of Photochemistry</span>, CRC/Taylor &amp; Francis, Boca Raton,  2006 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Handbook%20of%20Photochemistry%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202006%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit22">M. Sitkovsky and D. Lukashev, <span class="italic">Nat. Rev. Immunol.</span>, 2005, <span class="bold">5</span>, 712–721 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nri1685" title="DOI Link to resource 10.1038/nri1685">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXpslakurs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit23">J. M. Brown and W. R. Wilson, <span class="italic">Nat. Rev. Cancer</span>, 2004, <span class="bold">4</span>, 437–447 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrc1367" title="DOI Link to resource 10.1038/nrc1367">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXksVaisbs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit24">J. Moan, <span class="italic">J. Photochem. Photobiol., B</span>, 1990, <span class="bold">6</span>, 343–344 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/1011-1344(90)85104-5" title="DOI Link to resource 10.1016/1011-1344(90)85104-5">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3cXltFWksr0%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit25">M. K. Kuimova, G. Yahioglu and P. R. Ogilby, <span class="italic">J. Am. Chem. Soc.</span>, 2009, <span class="bold">131</span>, 332–340 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja807484b" title="DOI Link to resource 10.1021/ja807484b">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs73N" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit26">M. Niedre, M. S. Patterson and B. C. Wilson, <span class="italic">Photochem. Photobiol.</span>, 2002, <span class="bold">75</span>, 382–391 <a target="_blank" class="DOILink" href="https://doi.org/10.1562/0031-8655(2002)0750382DNILDO2.0.CO2" title="DOI Link to resource 10.1562/0031-8655(2002)0750382DNILDO2.0.CO2">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38Xjt1altb8%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit27">S. M. Hahn, M. E. Putt, J. Metz, D. B. Shin, E. Rickter, C. Menon, D. Smith, E. Glatstein, D. L. Fraker and T. M. Busch, <span class="italic">Clin. Cancer Res.</span>, 2006, <span class="bold">12</span>, 5464–5470 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/1078-0432.CCR-06-0953" title="DOI Link to resource 10.1158/1078-0432.CCR-06-0953">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XpvFShsbo%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit28">T. M. Busch, S. M. Hahn, E. P. Wileyto, C. J. Koch, D. L. Fraker, P. Zhang, M. Putt, K. Gleason, D. B. Shin, M. J. Emanuele, K. Jenkins, E. Glatstein and S. M. Evans, <span class="italic">Clin. Cancer Res.</span>, 2004, <span class="bold">10</span>, 4630–4638 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/1078-0432.CCR-04-0359" title="DOI Link to resource 10.1158/1078-0432.CCR-04-0359">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXlvVehu7w%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit29">T. M. Busch, E. P. Wileyto, M. J. Emanuele, F. Del Piero, L. Marconato, E. Glatstein and C. J. Koch, <span class="italic">Cancer Res.</span>, 2002, <span class="bold">62</span>, 7273–7279 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXhtVyquw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit30">F. Wilkinson, W. P. Helman and A. B. Ross, <span class="italic">J. Phys. Chem. Ref. Data</span>, 1995, <span class="bold">24</span>, 663–1021 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.555965" title="DOI Link to resource 10.1063/1.555965">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK2MXmtlamtLw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit31">F. Wilkinson, W. P. Helman and A. B. Ross, <span class="italic">J. Phys. Chem. Ref. Data</span>, 1993, <span class="bold">22</span>, 113–262 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.555934" title="DOI Link to resource 10.1063/1.555934">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3sXisVChu74%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit32">P. Juzenas, A. Juzeniene, O. Kaalhus, V. Iani and J. Moan, <span class="italic">Photochem. Photobiol. Sci.</span>, 2002, <span class="bold">1</span>, 745–748 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XnsFylt7k%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit33">B. Paul, P. Rajaputra and Y. You, <span class="italic">Photochem. Photobiol.</span>, 2011, <span class="bold">87</span>, 1468–1473 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1751-1097.2011.00988.x" title="DOI Link to resource 10.1111/j.1751-1097.2011.00988.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7bP" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit34">H. von Tappeiner and A. Jesionek, <span class="italic">MMW Munch. Med. Wochenschr.</span>, 1903, <span class="bold">47</span>, 2042–2044 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=MMW%20Munch.%20Med.%20Wochenschr.%5BJour%5D%20AND%2047%5Bvolume%5D%20AND%202042%5Bpage%5D%20and%201903%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit35">H. v. Tappeiner, <span class="italic">Ergeb. Physiol.</span>, 1909, <span class="bold">8</span>, 698–741 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/BF02321096" title="DOI Link to resource 10.1007/BF02321096">CrossRef</a>.</span></li>
      <li><span id="cit36">A. Policard, <span class="italic">C. R. Seances Soc. Biol.</span>, 1924, <span class="bold">91</span>, 1423–1424 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=C.%20R.%20Seances%20Soc.%20Biol.%5BJour%5D%20AND%2091%5Bvolume%5D%20AND%201423%5Bpage%5D%20and%201924%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit37">H. Auler and G. Banzer, <span class="italic">Z. Krebsforsch.</span>, 1942, <span class="bold">53</span>, 65–68 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/BF01792783" title="DOI Link to resource 10.1007/BF01792783">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaH2cXjtFKgsg%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit38">R. L. Lipson and E. J. Baldes, <span class="italic">Arch. Dermatol.</span>, 1960, <span class="bold">82</span>, 508–516 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaF3cXht12lurw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit39">R. L. Lipson, E. J. Baldes and A. M. Olsen, <span class="italic">J. Natl. Cancer Inst.</span>, 1961, <span class="bold">26</span>, 1–11 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaF3MXksVektQ%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit40">R. L. Lipson, E. J. Baldes and A. M. Olsen, <span class="italic">J. Thorac. Cardiovasc. Surg.</span>, 1961, <span class="bold">42</span>, 623–629 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaF38%252FmslaisA%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit41">R. L. Lipson, E. J. Baldes and M. J. Gray, <span class="italic">Cancer</span>, 1967, <span class="bold">20</span>, 2255–2257 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/1097-0142(196712)20:12&lt;2255::AID-CNCR2820201229&gt;3.0.CO;2-U" title="DOI Link to resource 10.1002/1097-0142(196712)20:12&lt;2255::AID-CNCR2820201229&gt;3.0.CO;2-U">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaF1c%252FptlSgtw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit42">R. L. Lipson, E. J. Baldes and A. M. Olsen, <span class="italic">Chest</span>, 1964, <span class="bold">46</span>, 676–679 <a target="_blank" class="DOILink" href="https://doi.org/10.1378/chest.46.6.676" title="DOI Link to resource 10.1378/chest.46.6.676">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaF2M%252Flt12rug%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit43">T. J. Dougherty, G. B. Grindey, R. Fiel, K. R. Weishaupt and D. G. Boyle, <span class="italic">J. Natl. Cancer Inst.</span>, 1975, <span class="bold">55</span>, 115–121 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaE28%252FgslGqsw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit44">J. F. Kelly, <span class="italic">Proc. R. Soc. Med.</span>, 1975, <span class="bold">68</span>, 527–528 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaE28%252FnvVKisA%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit45">J. F. Kelly, M. E. Snell and M. C. Berenbaum, <span class="italic">Br. J. Cancer</span>, 1975, <span class="bold">31</span>, 237–244 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/bjc.1975.30" title="DOI Link to resource 10.1038/bjc.1975.30">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaE28%252FhvVOqsQ%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit46">Y.-J. Hsieh, C.-C. Wu, C.-J. Chang and J.-S. Yu, <span class="italic">J. Cell. Physiol.</span>, 2003, <span class="bold">194</span>, 363–375 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/jcp.10273" title="DOI Link to resource 10.1002/jcp.10273">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXhtFKiu7g%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit47">M. Wainwright, <span class="italic">Chem. Soc. Rev.</span>, 1996, <span class="bold">25</span>, 351–359 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=CS9962500351&amp;newsite=1" title="Link to RSC resource DOI:10.1039/CS9962500351">RSC</a>.</span></li>
      <li><span id="cit48">D. E. J. G. J. Dolmans, D. Fukumura and R. K. Jain, <span class="italic">Nat. Rev. Cancer</span>, 2003, <span class="bold">3</span>, 380–387 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrc1071" title="DOI Link to resource 10.1038/nrc1071">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXjtlals74%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit49">R. Bonnett, <span class="italic">Chem. Soc. Rev.</span>, 1995, <span class="bold">24</span>, 19–33 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=CS9952400019&amp;newsite=1" title="Link to RSC resource DOI:10.1039/CS9952400019">RSC</a>.</span></li>
      <li><span id="cit50">E. D. Sternberg, D. Dolphin and C. Bruckner, <span class="italic">Tetrahedron</span>, 1998, <span class="bold">54</span>, 4151–4202 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0040-4020(98)00015-5" title="DOI Link to resource 10.1016/S0040-4020(98)00015-5">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1cXisFGlt7c%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit51">R. R. Allison, G. H. Downie, R. Cuenca, X.-H. Hu, C. J. H. Childs and C. H. Sibata, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2004, <span class="bold">1</span>, 27–42 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1572-1000(04)00007-9" title="DOI Link to resource 10.1016/S1572-1000(04)00007-9">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXjtVGrurs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit52">E. S. Nyman and P. H. Hynninen, <span class="italic">J. Photochem. Photobiol., B</span>, 2004, <span class="bold">73</span>, 1–28 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jphotobiol.2003.10.002" title="DOI Link to resource 10.1016/j.jphotobiol.2003.10.002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXjsVyhtA%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit53">M. R. Detty, S. L. Gibson and S. J. Wagner, <span class="italic">J. Med. Chem.</span>, 2004, <span class="bold">47</span>, 3897–3915 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm040074b" title="DOI Link to resource 10.1021/jm040074b">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXkvFyht7c%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit54">R. K. Pandey, L. N. Goswami, Y. Chen, A. Gryshuk, J. R. Missert, A. Oseroff and T. J. Dougherty, <span class="italic">Lasers Surg. Med.</span>, 2006, <span class="bold">38</span>, 445–467 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/lsm.20352" title="DOI Link to resource 10.1002/lsm.20352">CrossRef</a>.</span></li>
      <li><span id="cit55">A. E. O'Connor, W. M. Gallagher and A. T. Byrne, <span class="italic">Photochem. Photobiol.</span>, 2009, <span class="bold">85</span>, 1053–1074 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1751-1097.2009.00585.x" title="DOI Link to resource 10.1111/j.1751-1097.2009.00585.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXht1amsbnL" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit56">A. J. Bullous, C. M. Alonso and R. W. Boyle, <span class="italic">Photochem. Photobiol. Sci.</span>, 2011, <span class="bold">10</span>, 721–750 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXltleisbg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit57">M. Ethirajan, Y. H. Chen, P. Joshi and R. K. Pandey, <span class="italic">Chem. Soc. Rev.</span>, 2011, <span class="bold">40</span>, 340–362 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B915149B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B915149B">RSC</a>.</span></li>
      <li><span id="cit58">J. F. Lovell, T. W. Liu, J. Chen and G. Zheng, <span class="italic">Chem. Rev.</span>, 2010, <span class="bold">110</span>, 2839–2857 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr900236h" title="DOI Link to resource 10.1021/cr900236h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXht1Sgu7k%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit59">S. Gross, A. Gilead, A. Scherz, M. Neeman and Y. Salomon, <span class="italic">Nat. Med.</span>, 2003, <span class="bold">9</span>, 1327–1331 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nm940" title="DOI Link to resource 10.1038/nm940">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXns1Cksro%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit60">L. B. Josefsen and R. W. Boyle, <span class="italic">Br. J. Pharmacol.</span>, 2008, <span class="bold">154</span>, 1–3 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/bjp.2008.98" title="DOI Link to resource 10.1038/bjp.2008.98">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXltFOqtrw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit61">M. O. Senge, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2012, <span class="bold">9</span>, 170–179 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.pdpdt.2011.10.001" title="DOI Link to resource 10.1016/j.pdpdt.2011.10.001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xnt1yrsL8%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit62">M. Mitsunaga, M. Ogawa, N. Kosaka, L. T. Rosenblum, P. L. Choyke and H. Kobayashi, <span class="italic">Nat. Med.</span>, 2011, <span class="bold">17</span>, 1685–1691 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nm.2554" title="DOI Link to resource 10.1038/nm.2554">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagurrP" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit63">J. P. Celli, B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue and T. Hasan, <span class="italic">Chem. Rev.</span>, 2010, <span class="bold">110</span>, 2795–2838 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr900300p" title="DOI Link to resource 10.1021/cr900300p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqt7o%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit64">S. S. Kelkar and T. M. Reineke, <span class="italic">Bioconjugate Chem.</span>, 2011, <span class="bold">22</span>, 1879–1903 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/bc200151q" title="DOI Link to resource 10.1021/bc200151q">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2jt77K" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit65">G. Zilidis, F. Aziz, S. Telara and M. S. Eljamel, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2008, <span class="bold">5</span>, 264–266 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.pdpdt.2009.01.001" title="DOI Link to resource 10.1016/j.pdpdt.2009.01.001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXkslKhsro%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit66">M. S. Eljamel, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2008, <span class="bold">5</span>, 260–263 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.pdpdt.2008.11.003" title="DOI Link to resource 10.1016/j.pdpdt.2008.11.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXkslKhsrw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit67">M. Mitsunaga, T. Nakajima, K. Sano, P. L. Choyke and H. Kobayashi, <span class="italic">Bioconjugate Chem.</span>, 2012, <span class="bold">23</span>, 604–609 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/bc200648m" title="DOI Link to resource 10.1021/bc200648m">CrossRef</a>.</span></li>
      <li><span id="cit68">G. Ulrich, R. Ziessel and A. Harriman, <span class="italic">Angew. Chem., Int. Ed.</span>, 2008, <span class="bold">47</span>, 1184–1201 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200702070" title="DOI Link to resource 10.1002/anie.200702070">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXit1Gqs7w%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit69">
          R. P. Haugland, <span class="italic">The Handbook: A guide to Fluorerscent Probes and Labeling Technologies</span>, 10th edn, Invitrogen Corp., Eugene, OR,  2005 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=The%20Handbook:%20A%20guide%20to%20Fluorerscent%20Probes%20and%20Labeling%20Technologies%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202005%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit70">K. Umezawa, Y. Nakamura, H. Makino, D. Citterio and K. Suzuki, <span class="italic">J. Am. Chem. Soc.</span>, 2008, <span class="bold">130</span>, 1550 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja077756j" title="DOI Link to resource 10.1021/ja077756j">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXlsl2rsQ%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit71">M. A. T. Rogers, <span class="italic">Nature</span>, 1943, <span class="bold">151</span>, 504 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/151504a0" title="DOI Link to resource 10.1038/151504a0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaH3sXislamug%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit72">M. A. T. Rogers, <span class="italic">J. Chem. Soc.</span>, 1943, 590–596 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=JR9430000590&amp;newsite=1" title="Link to RSC resource DOI:10.1039/JR9430000590">RSC</a>.</span></li>
      <li><span id="cit73">A. Treibs and F. H. Kreuzer, <span class="italic">Justus Liebigs Ann. Chem.</span>, 1986, <span class="bold">718</span>, 208 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Justus%20Liebigs%20Ann.%20Chem.%5BJour%5D%20AND%20718%5Bvolume%5D%20AND%20208%5Bpage%5D%20and%201986%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit74">J. Killoran, L. Allen, J. F. Gallagher, W. M. Gallagher and D. F. O'Shea, <span class="italic">Chem. Commun.</span>, 2002, 1862–1863 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B204317C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B204317C">RSC</a>.</span></li>
      <li><span id="cit75">T. Yogo, Y. Urano, Y. Ishitsuka, F. Maniwa and T. Nagano, <span class="italic">J. Am. Chem. Soc.</span>, 2005, <span class="bold">127</span>, 12162–12163 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja0528533" title="DOI Link to resource 10.1021/ja0528533">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXns1aisrs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit76">A. T. Byrne, A. E. O'Connor, M. Hall, J. Murtagh, K. O'Neill, K. M. Curran, K. Mongrain, J. A. Rousseau, R. Lecomte, S. McGee, J. J. Callanan, D. F. O'Shea and W. M. Gallagher, <span class="italic">Br. J. Cancer</span>, 2009, <span class="bold">101</span>, 1565–1573 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/sj.bjc.6605247" title="DOI Link to resource 10.1038/sj.bjc.6605247">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsr%252FJ" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit77">
          <span class="italic">IUPAC Compendium of Chemical Terminology</span>, ed. A. D. McNaught and A. Wilkinson, Blackwell Scientific Publications, Oxford, UK, 2nd edn,  1997, vol. 68, p. 2245 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=IUPAC%20Compendium%20of%20Chemical%20Terminology%5BJour%5D%20AND%20vol. 68%5Bvolume%5D%20AND%20%5Bpage%5D%20and%201997%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit78">E. Deniz, G. C. Isbasar, O. A. Bozdemir, L. T. Yildirim, A. Siemiarczuk and E. U. Akkaya, <span class="italic">Org. Lett.</span>, 2008, <span class="bold">10</span>, 3401–3403 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol801062h" title="DOI Link to resource 10.1021/ol801062h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXotlGmu7Y%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit79">Z. Dost, S. Atilgan and E. U. Akkaya, <span class="italic">Tetrahedron</span>, 2006, <span class="bold">62</span>, 8484–8488 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tet.2006.06.082" title="DOI Link to resource 10.1016/j.tet.2006.06.082">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XnvVSmtL0%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit80">A. Cihaner and F. Algi, <span class="italic">React. Funct. Polym.</span>, 2009, <span class="bold">69</span>, 62–67 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.reactfunctpolym.2008.10.011" title="DOI Link to resource 10.1016/j.reactfunctpolym.2008.10.011">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2itbg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit81">Y. Hayashi, S. Yamaguchi, W. Y. Cha, D. Kim and H. Shinokubo, <span class="italic">Org. Lett.</span>, 2011, <span class="bold">13</span>, 2992–2995 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol200799u" title="DOI Link to resource 10.1021/ol200799u">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXmt1Ggtrs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit82">M. T. K. Shah, M.-L. Soong, L. T. Wolford, J. H. Boyer, I. R. Politzer and T.G. Pavlopoulos, <span class="italic">Heteroat. Chem.</span>, 1990, <span class="bold">1</span>, 389 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/hc.520010507" title="DOI Link to resource 10.1002/hc.520010507">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3MXktlWju7g%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit83">A. Gorman, J. Killoran, C. O'Shea, T. Kenna, W. M. Gallagher and D. F. O'Shea, <span class="italic">J. Am. Chem. Soc.</span>, 2004, <span class="bold">126</span>, 10619–10631 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja047649e" title="DOI Link to resource 10.1021/ja047649e">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXmsVWjtb4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit84">P. Batat, M. Cantuel, G. Jonusauskas, L. Scarpantonio, A. Palma, D. F. O'Shea and N. D. McClenaghan, <span class="italic">J. Phys. Chem. A</span>, 2011, <span class="bold">115</span>, 14034–14039 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp2077775" title="DOI Link to resource 10.1021/jp2077775">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsbbI" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit85">L. Jiao, W. Pang, J. Zhou, Y. Wei, X. Mu, G. Bai and E. Hao, <span class="italic">J. Org. Chem.</span>, 2011, <span class="bold">76</span>, 9988–9996 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo201754m" title="DOI Link to resource 10.1021/jo201754m">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGkt7vN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit86">X. Li, S. Huang and Y. Hu, <span class="italic">Org. Biomol. Chem.</span>, 2012, <span class="bold">10</span>, 2369–2372 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Ghu7o%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit87">S. G. Awuah, J. Polreis, V. Biradar and Y. You, <span class="italic">Org. Lett.</span>, 2011 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Org.%20Lett.%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit88">M. J. Ortiz, A. R. Agarrabeitia, G. Duran-Sampedro, J. Bañuelos Prieto, T. A. Lopez, W. A. Massad, H. A. Montejano, N. A. García and I. L. Arbeloa, <span class="italic">Tetrahedron</span>, 2012, <span class="bold">68</span>, 1153–1162 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tet.2011.11.070" title="DOI Link to resource 10.1016/j.tet.2011.11.070">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xks1yruw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit89">N. Adarsh, R. R. Avirah and D. Ramaiah, <span class="italic">Org. Lett.</span>, 2010, <span class="bold">12</span>, 5720–5723 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol102562k" title="DOI Link to resource 10.1021/ol102562k">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsVCjs7%252FO" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit90">N. Adarsh, R. R. Avirah and D. Ramaiah, <span class="italic">Org. Lett.</span>, 2011, <span class="bold">13</span>, 2146–2146 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol200572p" title="DOI Link to resource 10.1021/ol200572p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXivFygsL4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit91">S. H. Lim, C. Thivierge, P. Nowak-Sliwinska, J. Han, H. van den Bergh, G. Wagnieres, K. Burgess and H. B. Lee, <span class="italic">J. Med. Chem.</span>, 2010, <span class="bold">53</span>, 2865–2874 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm901823u" title="DOI Link to resource 10.1021/jm901823u">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXis1Oqu74%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit92">D. Wang, J. Fan, X. Gao, B. Wang, S. Sun and X. Peng, <span class="italic">J. Org. Chem.</span>, 2009, <span class="bold">74</span>, 7675–7683 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo901149y" title="DOI Link to resource 10.1021/jo901149y">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKgu7jN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit93">Z. Li, E. Mintzer and R. Bittman, <span class="italic">J. Org. Chem.</span>, 2006, <span class="bold">71</span>, 1718–1721 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo052029x" title="DOI Link to resource 10.1021/jo052029x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XjvV2qsw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit94">V. Gottfried, E. S. Lindenbaum and S. Kimel, <span class="italic">Int. J. Radiat. Biol.</span>, 1991, <span class="bold">60</span>, 349–354 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/09553009114552121" title="DOI Link to resource 10.1080/09553009114552121">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaK3MzisVOqsA%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit95">V. Gottfried, E. S. Lindenbaum and S. Kimel, <span class="italic">J. Photochem. Photobiol., B</span>, 1992, <span class="bold">12</span>, 204–207 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/1011-1344(92)85010-R" title="DOI Link to resource 10.1016/1011-1344(92)85010-R">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaK38zhvVSruw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit96">R. Weissleder, <span class="italic">Nat. Biotechnol.</span>, 2001, <span class="bold">19</span>, 316–317 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/86684" title="DOI Link to resource 10.1038/86684">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXis1SmsLg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit97">J. Chen, A. Burghart, A. Derecskei-Kovacs and K. Burgess, <span class="italic">J. Org. Chem.</span>, 2000, <span class="bold">65</span>, 2900–2906 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo991927o" title="DOI Link to resource 10.1021/jo991927o">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXisVKrsr4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit98">Y. J. Mei, P. A. Bentley and W. Wang, <span class="italic">Tetrahedron Lett.</span>, 2006, <span class="bold">47</span>, 2447–2449 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tetlet.2006.01.091" title="DOI Link to resource 10.1016/j.tetlet.2006.01.091">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XitVOju7k%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit99">C. Thivierge, R. Bandichhor and K. Burgess, <span class="italic">Org. Lett.</span>, 2007, <span class="bold">9</span>, 2135–2138 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol0706197" title="DOI Link to resource 10.1021/ol0706197">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXksFSnsbY%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit100">T. Rohand, W. W. Qin, N. Boens and W. Dehaen, <span class="italic">Eur. J. Org. Chem.</span>, 2006, 4658–4663 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejoc.200600531" title="DOI Link to resource 10.1002/ejoc.200600531">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtFKnsbfP" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit101">L. J. Jiao, C. J. Yu, T. Uppal, M. M. Liu, Y. Li, Y. Y. Zhou, E. H. Hao, X. K. Hu and M. G. H. Vicente, <span class="italic">Org. Biomol. Chem.</span>, 2010, <span class="bold">8</span>, 2517–2519 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXmt1aqtLs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit102">J. Y. Han, O. Gonzalez, A. Aguilar-Aguilar, E. Pena-Cabrera and K. Burgess, <span class="italic">Org. Biomol. Chem.</span>, 2009, <span class="bold">7</span>, 34–36 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsVylsr7N" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit103">T. Rohand, M. Baruah, W. W. Qin, N. Boens and W. Dehaen, <span class="italic">Chem. Commun.</span>, 2006, 266–268 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B512756D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B512756D">RSC</a>.</span></li>
      <li><span id="cit104">T. Rousseau, A. Cravino, T. Bura, G. Ulrich, R. Ziessel and J. Roncali, <span class="italic">Chem. Commun.</span>, 2009, 1673–1675 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B822770E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B822770E">RSC</a>.</span></li>
      <li><span id="cit105">J. Y. Liu, E. A. Ermilov, B. Roder and D. K. P. Ng, <span class="italic">Chem. Commun.</span>, 2009, 1517–1519 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B821630D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B821630D">RSC</a>.</span></li>
      <li><span id="cit106">O. Buyukcakir, O. A. Bozdemir, S. Kolemen, S. Erbas and E. U. Akkaya, <span class="italic">Org. Lett.</span>, 2009, <span class="bold">11</span>, 4644–4647 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol9019056" title="DOI Link to resource 10.1021/ol9019056">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7zI" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit107">M. Wada, S. Ito, H. Uno, T. Murashima, N. Ono, T. Urano and Y. Urano, <span class="italic">Tetrahedron Lett.</span>, 2001, <span class="bold">42</span>, 6711–6713 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0040-4039(01)01299-0" title="DOI Link to resource 10.1016/S0040-4039(01)01299-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXmt1yqt7o%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit108">Z. Shen, H. Rohr, K. Rurack, H. Uno, M. Spieles, B. Schulz, G. Reck and N. Ono, <span class="italic">Chem.–Eur. J.</span>, 2004, <span class="bold">10</span>, 4853–4871 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.200400173" title="DOI Link to resource 10.1002/chem.200400173">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXoslegu7g%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit109">S. Goeb and R. Ziessel, <span class="italic">Org. Lett.</span>, 2007, <span class="bold">9</span>, 737–740 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol0627404" title="DOI Link to resource 10.1021/ol0627404">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWmsbg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit110">G. Ulrich, S. Goeb, A. De Nicola, P. Retailleau and R. Ziessel, <span class="italic">Synlett</span>, 2007, 1517–1520 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/s-2007-982557" title="DOI Link to resource 10.1055/s-2007-982557">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXotVymsr0%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit111">L. J. Jiao, C. J. Yu, M. M. Liu, Y. C. Wu, K. B. Cong, T. Meng, Y. Q. Wang and E. H. Hao, <span class="italic">J. Org. Chem.</span>, 2010, <span class="bold">75</span>, 6035–6038 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo101164a" title="DOI Link to resource 10.1021/jo101164a">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKisLk%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit112">
          J. Griffiths, in <span class="italic">Modern Colorants: synthesis and structure</span>, Blackie Academic and Professional, Glasgow, U. K.,  1995 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Modern%20Colorants:%20synthesis%20and%20structure%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%201995%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit113">G. Qian and Z. Y. Wang, <span class="italic">Chem.–Asian J.</span>, 2010, <span class="bold">5</span>, 1006–1029 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/asia.200900596" title="DOI Link to resource 10.1002/asia.200900596">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXls1Wktbw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit114">J. Chen, A. Burghart, A. Derecskei-Kovacs and K. Burgess, <span class="italic">J. Org. Chem.</span>, 2000, <span class="bold">65</span>, 2900–2906 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo991927o" title="DOI Link to resource 10.1021/jo991927o">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXisVKrsr4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit115">A. Coskun, E. Deniz and E. U. Akkaya, <span class="italic">Org. Lett.</span>, 2005, <span class="bold">7</span>, 5187–5189 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol052020h" title="DOI Link to resource 10.1021/ol052020h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWku7fN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit116">S. Atilgan, Z. Ekmekci, A. L. Dogan, D. Guc and E. U. Akkaya, <span class="italic">Chem. Commun.</span>, 2006, 4398–4400 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B612347C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B612347C">RSC</a>.</span></li>
      <li><span id="cit117">H. He, P. C. Lo, S. L. Yeung, W. P. Fong and D. K. Ng, <span class="italic">J. Med. Chem.</span>, 2011, <span class="bold">54</span>, 3097–3102 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm101637g" title="DOI Link to resource 10.1021/jm101637g">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXjsFKgtL0%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit118">M. R. Hamblin, J. L. Miller, I. Rizvi, B. Ortel, E. V. Maytin and T. Hasan, <span class="italic">Cancer Res.</span>, 2001, <span class="bold">61</span>, 7155–7162 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXnsVehsbc%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit119">S. K. Sahoo, T. Sawa, J. Fang, S. Tanaka, Y. Miyamoto, T. Akaike and H. Maeda, <span class="italic">Bioconjugate Chem.</span>, 2002, <span class="bold">13</span>, 1031–1038 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/bc020010k" title="DOI Link to resource 10.1021/bc020010k">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XltlWksLg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit120">V. Rapozzi, M. Zacchigna, S. Biffi, C. Garrovo, F. Cateni, M. Stebel, S. Zorzet, G. M. Bonora, S. Drioli and L. Xodo, <span class="italic">Cancer Biol. Ther.</span>, 2010, <span class="bold">10</span>, 471–482 <a target="_blank" class="DOILink" href="https://doi.org/10.4161/cbt.10.5.12536" title="DOI Link to resource 10.4161/cbt.10.5.12536">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhs1akurvJ" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit121">H. He, P.-C. Lo, S.-L. Yeung, W.-P. Fong and D. K. P. Ng, <span class="italic">Chem. Commun.</span>, 2011, <span class="bold">47</span>, 4748–4750 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C1CC10727E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C1CC10727E">RSC</a>.</span></li>
      <li><span id="cit122">S. Erbas, A. Gorgulu, M. Kocakusakogullari and E. U. Akkaya, <span class="italic">Chem. Commun.</span>, 2009, 4956–4958 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B908485A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B908485A">RSC</a>.</span></li>
      <li><span id="cit123">S. Kim, T. Y. Ohulchanskyy, A. Baev and P. N. Prasad, <span class="italic">J. Mater. Chem.</span>, 2009, <span class="bold">19</span>, 3181–3188 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B813396D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B813396D">RSC</a>.</span></li>
      <li><span id="cit124">S. K. Lower and M. A. Elsayed, <span class="italic">Chem. Rev.</span>, 1996, <span class="bold">66</span>, 199 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr60240a004" title="DOI Link to resource 10.1021/cr60240a004">CrossRef</a>.</span></li>
      <li><span id="cit125">A. K. Chandra, N. J. Turro, A. L. Lyons and P. Stone, <span class="italic">J. Am. Chem. Soc.</span>, 1978, <span class="bold">100</span>, 4964–4968 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja00484a007" title="DOI Link to resource 10.1021/ja00484a007">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE1cXlsVKhtL4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit126">J. C. Koziar and D. O. Cowan, <span class="italic">Acc. Chem. Res.</span>, 1978, <span class="bold">11</span>, 334–341 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar50129a003" title="DOI Link to resource 10.1021/ar50129a003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE1cXlt1ymur8%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit127">S. P. Mcglynn, R. Sunseri and N. Christod, <span class="italic">J. Chem. Phys.</span>, 1962, <span class="bold">37</span>, 1818 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.1733374" title="DOI Link to resource 10.1063/1.1733374">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaF3sXhtVSh" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit128">S. P. Mcglynn, G. W. Daigre, N. Christodoyleas and M. J. Reynolds, <span class="italic">J. Phys. Chem.</span>, 1962, <span class="bold">66</span>, 2499 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/j100818a042" title="DOI Link to resource 10.1021/j100818a042">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaF3sXltVWlsA%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit129">P. Yuster and S. I. Weissman, <span class="italic">J. Chem. Phys.</span>, 1949, <span class="bold">17</span>, 1182–1188 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.1747140" title="DOI Link to resource 10.1063/1.1747140">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaG3cXisVCjsg%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit130">D. S. Mcclure, <span class="italic">J. Chem. Phys.</span>, 1949, <span class="bold">17</span>, 665–666 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.1747359" title="DOI Link to resource 10.1063/1.1747359">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaH1MXkvFKitA%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit131">D. S. Mcclure, <span class="italic">J. Chem. Phys.</span>, 1949, <span class="bold">17</span>, 905–913 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.1747085" title="DOI Link to resource 10.1063/1.1747085">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaG3cXpsVWj" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit132">W. M. Gallagher, L. T. Allen, C. O'Shea, T. Kenna, M. Hall, A. Gorman, J. Killoran and D. F. O'Shea, <span class="italic">Br. J. Cancer</span>, 2005, <span class="bold">92</span>, 1702–1710 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/sj.bjc.6602527" title="DOI Link to resource 10.1038/sj.bjc.6602527">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXjvVansLs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit133">B. Chen, B. W. Pogue, P. J. Hoopes and T. Hasan, <span class="italic">Crit. Rev. Eukaryotic Gene Expression</span>, 2006, <span class="bold">16</span>, 279–305 <a target="_blank" class="DOILink" href="https://doi.org/10.1615/CritRevEukarGeneExpr.v16.i4.10" title="DOI Link to resource 10.1615/CritRevEukarGeneExpr.v16.i4.10">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXksl2gtg%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit134">B. Chen, B. W. Pogue, J. M. Luna, R. L. Hardman, P. J. Hoopes and T. Hasan, <span class="italic">Clin. Cancer Res.</span>, 2006, <span class="bold">12</span>, 917–923 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/1078-0432.CCR-05-1673" title="DOI Link to resource 10.1158/1078-0432.CCR-05-1673">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtFeiu7g%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit135">A. E. O'Connor, M. M. Mc Gee, Y. Likar, V. Ponomarev, J. J. Callanan, F. D. O'Shea, A. T. Byrne and W. M. Gallagher, <span class="italic">Int. J. Cancer</span>, 2012, <span class="bold">130</span>, 705–715 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ijc.26073" title="DOI Link to resource 10.1002/ijc.26073">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaru73E" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit136">T. Maisch, <span class="italic">Mini-Rev. Med. Chem.</span>, 2009, <span class="bold">9</span>, 974–983 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXptVahsLg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit137">G. Bertoloni, F. Rossi, G. Valduga, G. Jori and J. Vanlier, <span class="italic">FEMS Microbiol. Lett.</span>, 1990, <span class="bold">71</span>, 149–155 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1574-6968.1990.tb03814.x" title="DOI Link to resource 10.1111/j.1574-6968.1990.tb03814.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3cXmt1Oru7Y%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit138">Y. Nitzan, M. Gutterman, Z. Malik and B. Ehrenberg, <span class="italic">Photochem. Photobiol.</span>, 1992, <span class="bold">55</span>, 89–96 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1751-1097.1992.tb04213.x" title="DOI Link to resource 10.1111/j.1751-1097.1992.tb04213.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK38XhtVWrsbk%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit139">Z. Malik, H. Ladan and Y. Nitzan, <span class="italic">J. Photochem. Photobiol., B</span>, 1992, <span class="bold">14</span>, 262–266 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/1011-1344(92)85104-3" title="DOI Link to resource 10.1016/1011-1344(92)85104-3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaK3s%252FlvVWgtQ%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit140">M. R. Hamblin, D. A. O'Donnell, N. Murthy, C. H. Contag and T. Hasan, <span class="italic">Photochem. Photobiol.</span>, 2002, <span class="bold">75</span>, 51–57 <a target="_blank" class="DOILink" href="https://doi.org/10.1562/0031-8655(2002)075&lt;0051:RCOWIB&gt;2.0.CO;2" title="DOI Link to resource 10.1562/0031-8655(2002)075&lt;0051:RCOWIB&gt;2.0.CO;2">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XptFehsw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit141">T. Dai, G. P. Tegos, T. Zhiyentayev, E. Mylonakis and M. R. Hamblin, <span class="italic">Lasers Surg. Med.</span>, 2010, <span class="bold">42</span>, 38–44 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/lsm.20887" title="DOI Link to resource 10.1002/lsm.20887">CrossRef</a>.</span></li>
      <li><span id="cit142">R. Dosselli, M. Gobbo, E. Bolognini, S. Campestrini and E. Reddi, <span class="italic">ACS Med. Chem. Lett.</span>, 2010, <span class="bold">1</span>, 35–38 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ml900021y" title="DOI Link to resource 10.1021/ml900021y">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWlsrc%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit143">T. Maisch, C. Bosl, R. M. Szeimies, N. Lehn and C. Abels, <span class="italic">Antimicrob. Agents Chemother.</span>, 2005, <span class="bold">49</span>, 1542–1552 <a target="_blank" class="DOILink" href="https://doi.org/10.1128/AAC.49.4.1542-1552.2005" title="DOI Link to resource 10.1128/AAC.49.4.1542-1552.2005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Gjsbo%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit144">H. Mohr, B. Lambrecht and A. Selz, <span class="italic">Immunol. Invest.</span>, 1995, <span class="bold">24</span>, 73–85 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/08820139509062763" title="DOI Link to resource 10.3109/08820139509062763">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaK2M3ivFamtQ%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit145">M. Wainwright, H. Mohr and W. H. Walker, <span class="italic">J. Photochem. Photobiol., B</span>, 2007, <span class="bold">86</span>, 45–58 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jphotobiol.2006.07.005" title="DOI Link to resource 10.1016/j.jphotobiol.2006.07.005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28Xht12ks7rN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit146">O. E. Akilov, S. Kosaka, K. O'Riordan, X. Z. Song, M. Sherwood, T. J. Flotte, J. W. Foley and T. Hasan, <span class="italic">Chem. Biol.</span>, 2006, <span class="bold">13</span>, 839–847 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.chembiol.2006.06.008" title="DOI Link to resource 10.1016/j.chembiol.2006.06.008">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XoslOhu74%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit147">D. O. Frimannsson, M. Grossi, J. Murtagh, F. Paradisi and D. F. O'Shea, <span class="italic">J. Med. Chem.</span>, 2010, <span class="bold">53</span>, 7337–7343 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm100585j" title="DOI Link to resource 10.1021/jm100585j">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXht1ajt73I" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit148">Y. Cakmak, S. Kolemen, S. Duman, Y. Dede, Y. Dolen, B. Kilic, Z. Kostereli, L. T. Yildirim, A. L. Dogan, D. Guc and E. U. Akkaya, <span class="italic">Angew. Chem., Int. Ed.</span>, 2011, <span class="bold">50</span>, 11937–11941 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201105736" title="DOI Link to resource 10.1002/anie.201105736">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtleqsLbL" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit149">W. Pang, X.-F. Zhang, J. Zhou, C. Yu, E. Hao and L. Jiao, <span class="italic">Chem. Commun.</span>, 2012, <span class="bold">48</span>, 5437–5439 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2CC30915G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2CC30915G">RSC</a>.</span></li>
      <li><span id="cit150">A. N. Amin, M. E. El-Khouly, N. K. Subbaiyan, M. E. Zandler, S. Fukuzumi and F. D'Souza, <span class="italic">Chem. Commun.</span>, 2012, <span class="bold">48</span>, 206–208 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C1CC16071K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C1CC16071K">RSC</a>.</span></li>
      <li><span id="cit151">L. Huang, X. Yu, W. Wu and J. Zhao, <span class="italic">Org. Lett.</span>, 2012, <span class="bold">14</span>, 2594–2597 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol3008843" title="DOI Link to resource 10.1021/ol3008843">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XmslGrt7c%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit152">S. Hoogendoorn, A. E. Blom, L. I. Willems, G. A. van der Marel and H. S. Overkleeft, <span class="italic">Org. Lett.</span>, 2011, <span class="bold">13</span>, 5656–5659 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol202379w" title="DOI Link to resource 10.1021/ol202379w">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7zK" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit153">S. Hoogendoorn, K. L. Habets, S. Passemard, J. Kuiper, G. A. van der Marel, B. I. Florea and H. S. Overkleeft, <span class="italic">Chem. Commun.</span>, 2011, <span class="bold">47</span>, 9363–9365 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C1CC12947C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C1CC12947C">RSC</a>.</span></li>
      <li><span id="cit154">Y. Urano, D. Asanuma, Y. Hama, Y. Koyama, T. Barrett, M. Kamiya, T. Nagano, T. Watanabe, A. Hasegawa, P. L. Choyke and H. Kobayashi, <span class="italic">Nat. Med.</span>, 2009, <span class="bold">15</span>, 104–109 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nm.1854" title="DOI Link to resource 10.1038/nm.1854">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu77M" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit155">T. Miura, Y. Urano, K. Tanaka, T. Nagano, K. Ohkubo and S. Fukuzumi, <span class="italic">J. Am. Chem. Soc.</span>, 2003, <span class="bold">125</span>, 8666–8671 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja035282s" title="DOI Link to resource 10.1021/ja035282s">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXks1Krtrw%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit156">T. Yogo, Y. Urano, A. Mizushima, H. Sunahara, T. Inoue, K. Hirose, M. Iino, K. Kikuchi and T. Nagano, <span class="italic">Proc. Natl. Acad. Sci. U. S. A.</span>, 2008, <span class="bold">105</span>, 28–32 <a target="_blank" class="DOILink" href="https://doi.org/10.1073/pnas.0611717105" title="DOI Link to resource 10.1073/pnas.0611717105">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXpvV2lug%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit157">S. O. McDonnell, M. J. Hall, L. T. Allen, A. Byrne, W. M. Gallagher and D. F. O'Shea, <span class="italic">J. Am. Chem. Soc.</span>, 2005, <span class="bold">127</span>, 16360–16361 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja0553497" title="DOI Link to resource 10.1021/ja0553497">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOisLzL" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit158">M. N. Win and C. D. Smolke, <span class="italic">Science</span>, 2008, <span class="bold">322</span>, 456–460 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.1160311" title="DOI Link to resource 10.1126/science.1160311">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXht1CitrrK" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit159">A. P. de Silva, M. R. James, B. O. McKinney, D. A. Pears and S. M. Weir, <span class="italic">Nat. Mater.</span>, 2006, <span class="bold">5</span>, 787–790 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nmat1733" title="DOI Link to resource 10.1038/nmat1733">CrossRef</a>.</span></li>
      <li><span id="cit160">R. J. Amir, M. Popkov, R. A. Lerner, C. F. Barbas 3rd and D. Shabat, <span class="italic">Angew. Chem., Int. Ed.</span>, 2005, <span class="bold">44</span>, 4378–4381 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200500842" title="DOI Link to resource 10.1002/anie.200500842">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXmvVehs7o%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit161">P. A. de Silva, N. H. Q. Gunaratne and C. P. McCoy, <span class="italic">Nature</span>, 1993, <span class="bold">364</span>, 42–44 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/364042a0" title="DOI Link to resource 10.1038/364042a0">CrossRef</a>.</span></li>
      <li><span id="cit162">K. Szacilowski, <span class="italic">Chem. Rev.</span>, 2008, <span class="bold">108</span>, 3481–3548 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr068403q" title="DOI Link to resource 10.1021/cr068403q">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXnvF2gs7s%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit163">P. Montcourrier, P. H. Mangeat, C. Valembois, G. Salazar, A. Sahuquet, C. Duperray and H. Rochefort, <span class="italic">J. Cell. Sci.</span>, 1994, <span class="bold">107</span>, 2381–2391 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Cell.%20Sci.%5BJour%5D%20AND%20107%5Bvolume%5D%20AND%202381%5Bpage%5D%20and%201994%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit164">I. L. Cameron, N. K. R. Smith, T. B. Pool and R. L. Sparks, <span class="italic">Cancer Res.</span>, 1980, <span class="bold">40</span>, 1493–1500 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL3cXktVGmtbk%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit165">S. Ozlem and E. U. Akkaya, <span class="italic">J. Am. Chem. Soc.</span>, 2008, <span class="bold">131</span>, 48–49 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja808389t" title="DOI Link to resource 10.1021/ja808389t">CrossRef</a>.</span></li>
      <li><span id="cit166">A. D. Quartarolo, N. Russo and E. Sicilia, <span class="italic">Chem.–Eur. J.</span>, 2006, <span class="bold">12</span>, 6797–6803 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.200501636" title="DOI Link to resource 10.1002/chem.200501636">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28Xps1ersL4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit167">S. Duman, Y. Cakmak, S. Kolemen, E. U. Akkaya and Y. Dede, <span class="italic">J. Org. Chem.</span>, 2012, <span class="bold">77</span>, 4516–4527 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo300051v" title="DOI Link to resource 10.1021/jo300051v">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhtL4%253D" title="Link to resource in CAS">CAS</a>.</span></li>
    </ol>
    
    
    
    
  <hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic Supplementary Information (ESI) available: a summary table of BODIPY-based photosensitizers: structures, optical properties, light dosimetry, cell line and <span class="CH"><a class="simple" title="ChEBI Ontology link for: drug" href="javascript:popupOBO('CHEBI:23888','c2ra21404k','http://www.ebi.ac.uk/chebi/searchId.do?chebiId=23888')">drug</a></span> doses. See DOI: <a href="http://xlink.rsc.org/?DOI=c2ra21404k" target="_blank" title="Select to resolve DOI: 10.1039/c2ra21404k">10.1039/c2ra21404k</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2012</b></td></tr></table></div></div></div></body><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>